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Abstract
Diet, as an integral. part of the environmental factors, has been
proposed as a major factor in the etiology of cancer. Under this
proposal, a number of food materials or drugs have been screened for
the effect on the growth and development of transplantable Ehrlich
ascites tumour cells. Garlic, margarine, L-histidine, L-lysine and
DL--methionine were found to have inhibition effect on the tumour.
As the shortened survival time in margarine treatment and pungent
smell of garlic, only amino acids supplementation are used in
further study. Three kinds of experiments are set out to investigate
the action of amino acids supplementation on EAT growth. The enzymic
pa' terns of aldola.se, acid. phosphatase, alkaline phosphatase, gluco-
kinase, glucose-6--phosphate dehydrogenase, fructose-1,6-diphosphatase,
lactate dehydrogenase and tyrosine aminotransferase, and the uptake
pattern of these three amino acids and nucleosides- thymidine and
urid.ine- in different organs are considered. For L-histidine, the
levels of blood glucose, blood cholesterol, glycogen in liver and
spleen are also measured. It is found that both EAT growth and amino
acids supplementation may affect the above parameters in different
manner.
Besides the experiments mentioned, the toxicity of these 3
essential amino acids is also noted and only the one in high concen-
tration seems to be toxic.
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Cancer, has existed on this planet long before mordern civiliza-
tion and industralization (Hegyeli and Hegyeli, 1981). Within this
hundred years, the knowledge about the cause and treatment of cancer
are extensively accumulated (Slaughter, 1959). It is proposed that
environmental factors may contribute greatly on carcinogenesis. Diet
has a major link between the individual and the environment. In 1975,
Poirier and Boutwell suggested that there might be a strong correla-
tion between dietary factors and carcinogenesis.
I. Epidemiological Evidences
Many epidemiological studies suggest that about 30 to 50% of
human cancers are related to nutritional factors. (Greenstein, 1954)
Dietary fat, a common nutrient, is supposed to have a significant
correlation between the incidences of different cancer in human being.
(Lea, 1966 Carroll, 1975 Raddy et.al., 1980) Statistically, the
age-adjusted mortality from cancer at breast, prostate, intestine,
rectum, lung, skin, stomach and liver in human being are found to have
a positive correlation with per caput consumption of dietary fat.
(Lea, 1966 Carroll, 19 75 Raddy et. al., 1980)
Epidemiologists also found that the breast cancer mortality shows
a strong positive correlation with caloric uptake, animal protein and
total protein ingested by human being. (Carroll and Khor, 1975) For
liver cancer, a tendency of negative correlation is shown between the
cancer death rate and dietary carbohydrate consumption. (Carroll and
Khor, 1975) Besides the relationships stated, the consumption of
minerals in diet is also correlated with the death rate of some
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cancers for example selenium (Shamberger et.al. 1976 Schrauzer et.
al. 1977), zinc (Stocks and Davis, 1964 McGlashan, 1972) and copper
(Schrauzer, 1978) affects breast cancer death rate.
As the relationship between the nutrition and cancer is highly
complex, the epidemiological studies cannot be considered as a
conclusive evidence but only be a hint for the study of the role of
nutrition on cancer.
II. Experimental Evidences
As early as 1914 Rous observed that the development of mammary
tumour in mouse was delayed by food restriction. Similar results had
also been obtained with chemically induced tumours (Tannenbaum, 1940
Tannenbaum and Silverstone, 1949 Dunning et.al., 1949 Moore and
Tittle, 1973) and other spontaneous tumours (Saxton et.al., 1944
Larsen and Heston, 1954 White, 1960 Ross et.al., 1970) under dietary
or carloric restriction. Opposite to dietary restriction, excessive
food appeared to increase tumourigenesis (Waxla et.al., 1953 Wells
and Alfin-Slater, 1979).
For the dietary fat, excess amount could promote the genesis of
certain kinds of cancer (Tannenbaum, 1942 Jaeobi and Baumann, 1946
Silverstone and Tannebaum, 1950 Silverstone and Tannuenbaum, 1951a).
But for the dietary protein, the actions are rather complicated and
no conclusive result was presented (Clayson, 1975 Wells and Alfin-
Slater, 1979).
Besides protein, fat and carbohydrate, vitamins and minerals are
also the nutrients present in the diet. Many experimental results
showed that certain kinds of vitamins had suppressing effect on some
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specific tumours. For example, the administration of vitamin A could
suppress the development of hydrocarbon induced skin cancer (Chu and
Ma1mgren, 1965 Shamberger, 1970 Bollag, 1971 Sporn et.al., 1976)
For minerals, the effect of them is quite contradictory and conflic-
ting. Relatively high content of copper salt in diet had been re-
ported to inhibit carcinogenesis (Howell, 1958 Kamanoto et.al., 1973).
But deficiency of zinc in diet was found to be able to inhibit some
kinds of tumours (DeWys and Pories, 1972 Duncan et. al., 1974 Pories
et.al., 1978 Minkel et.al., 1979).
From the epidemiological and experimental evidences, it seems
likely that certain kinds of food constituents or even the food itself
may play a role in carcinogenesis. This is the thought behind that
trigger this project.
The tumour system used in this experiment is Ehrlich ascites
tumour which is a transplantable tumour. The cells line is derived
from Ehrlich mouse carcinoma by Loewenthal John in 1932 and suggested
by Lette' (1941) that this cell line,is a good test object for the
effect of different substances on tumour growth. (Klein, 1950) By
now, the Ehrlich ascites tumour system is one of the most commonly
used system in the laboratories.
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Screening Test for the Effect of Foods and
Part One
Drugs on Ehrlich Ascites Tumour (EAT)
Introduction.
in vivo and in vitno SystemI.
The scope of the screening test is to investigate the relative
inhibitory and cytotoxic effects of different dietary materials.
The screening consists of two parts, in vivo and in vL o.
In in viva test,, the materials dissolved in drinking water
are administered to the mice inoculated with EAT cells. The
number of EAT cells developed after the experiment is counted.
The result is represented as% inhibition, which indicates the
inhibitory effect of the materials.
For in vitno test, only the materials which showed signifi-
cant effect on EAT in vivo test are studied. The EAT cells
are firstly preincubated with the materials. By using methylene
blue as viable count, the cytotoxicity is represented as relative
viability. In order to find the effect other than cytotoxicity,
the preincubated EAT cells are implanted into the mice to obtain
the% transplantibility.
Besides using preincubation, Ascites Agar Tube Method
(DiPaolo and Moore, 1960) is also employed to confirm the cyto-
toxicity of the substances. With the help of different dyes,
the possible action of certain compounds can be predicted.
II. Formulation of% Inhibition,% Viability and% Transplantibil.ity
The% inhibition,% viability and% transplantibility are
calculated as f ollowing:
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III. Description of Materials Screenec
Dependent on the availability during the experiment, dif¬
ferent kinds of food materials and drugs are selected and usee
in the screening test. They can be classified into 3 groups.
Gtioup A: Monosaccharides and their Derivatives
Although the theory concerned the role of dietary carbohy¬
drate on carcinogenesis was not well-established, experiments
showed that the. administration of D-mannose, D-ribose and D-
glucosamine reduced the growth of EAT (Gonzalez and Amos, 1977);
also D~glucosamine and 2-deoxy-D-glucose inhibited the growth of
Walker tumour (Ball et.al., 1956). In other experiments, mono¬
saccharides and their derivatives suppressed the respiration of
EAT cells -in )iXKO. (Brin and McKee, 1956) So, some of the
monosaccharides and their derivatives are screened Ui v-lvo .
GlOtip 8: Drugs of Chinese Medicine, Garlic and Onion
Three kinds of Chinese medicinal drugs, Decancerlin,
Anticancerlin and Oldenlandia, are chosen for the kn ukuo test
and they are named as their clinically anticancer ability.
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Besides the drugs, the fresh foods- bulb of garlic (Allium
sativum) and its related species, onion (Allium cepa) are also
used. It is noted that the lower incidence of cancer in Northern
China is probably related to the high consumption of garlic in
this area.
Besides the antibacterial (Carallito and Bailey, 1944),
antifungal activities (Yamada and Azuma, 1977) and the effect on
artherosclerosis (Angusti and Mattew, 1974; Chang and Johnson,
1980), allicin- the active principle of garlic (Carallito et.al.
1954; Stoll and Seebeck, 1951), and the crude extract of garlic
are suspected to exert suppressing activity on some specific
cancer. The crude extract of garlic was reported to have anti-
mitogenic activity on MTK- Sacroma III. Also, ingestion of
fresh garlic bulb had completely suppressed the growth of
mammary tumour
( 中 药 大 辞 典 ) Preincubation of the
tumour cells with allicin, the genesis of Sacroma 180 ascites
tumour cells (Weisberger and Pensky, 1958), Ehrlich-2-ascites and
L1210 ascites cells were prevented (DiPaolo and Carruthus, 1960).
But the oral intubation of allicin did not have any,effect on
Sacroma 180 ascites and Sacroma-180 (Weisberger and Pensky, 1957).
It is proposed that the antitumour effect of allicin is on
the conversion of -SH group to disulfide linkage (Harington,
1963). As -SH group is. related to cell division, the blockage
of this group can prevent cell multiplication (Weisberger and
Pensky, 1957; Harington, 1963). Due to the effect on -SH, tumour
development can then be suppressed by allicin.
7Gnoup C: Amino Acids
The role of the content of dietary protein on carcinogenesis
is quite complicated. This is due to the variation of quality
and quantity of the amino acids present in the protein (Wells
and Alfin-Slater, 1979). In order to clarify the of f ect, of these
variations, scientists modified dietary amino acids rather than
protein content and found this modification can affect the
genesis of cancer (Bounow and Kongshavn, 1981). Besides the
in total amino acids content, the experiments con-
cerned the role of single amino acid modified diet were also
studied. The supplementation of 5% arginine in caesin diet
reduced the growth of EAT and doubled the length of time of 50%
death of the animals (Milner and Stepanovich, 1979). Also, the
addition of arginine hydrochloride (4g/1) to the drinking water
of Balb/C mice before subcutaneous injection of myeloma cells
prevented the formation of tumour (Pryme, 1976) but cannot
prevent the production of Krebs II and 6C3HED lymphoma ascites
tumour in Balb/C and C3H mice respectively (Pryme, 1978). Pine
(1978) also reported that low phenylalanine diet can prolong the
survival of mice bearing ascites L1210 leukemia or P288. In our
laboratory, five amino acids are used for the screening process.
L-histidine, L-lysine and DL-methionine are found to be the most




The materials screened were obtained from the following
sources: bulbs of garlic and onion from market Purina chow from
Ralston Purina Chow Co. (USA) Anticancerlin from Shanghai Phar-
maceutical Industry Corporation (China) Decancerlin and Olden-
landia from Kwangtung Pharmaceutical Industry Corporation
(China) D-fructose, D-glucosa.mine hydrochloride, L-glutamine
and L-lysine hydrochloride from Merck Chemical Co. (Germany)
L-ornithine hydrochloride, L-arginine hydrochloride, L-histidine
hydrochloride, DL-methionine, basic fuchsin and toluidine blue
from Sigma Chemical Co. (USA) D-mannose from BDH Chemical Co.
(England) methylene blue from General Chemicals Pharmaceutical
Co. (England).
II. Methods
Preparation of Crude Extract of Garlic and Onion1.
Appropriated amount of garlic bulb was added to 100 ml
distilled water. The suspension was then homogenized,, stirred
for 30 minutes and then filtered under suction. The filtrate
obtained was used, as the crude extract in the following
experiments.
Harvest of Ehrlich Ascites Tumour2.
Ehrlich mouse ascites tumour cells, Ny Klein cell type,
were serially transplanted intraperitoneally at regular
intervals in Swiss mice, NMRI/BOM strain weighing 25 to 30
gm.
9For each experiment, mice were inoculated with 0.2 ml
diluted ascites fluid containing 3 x 105 cells at day 0. On
day 10, all the animals were killed by cervical dislocation.
The ascites fluid was totally collected by washing the
peritoneal cavity with phosphate buffered saline (PBS), pH
7.4. The cells were centrifuged at room temperature (25°C)
for 90 seconds at 3000 x g. The erythrocytes present in the
fluid were removed by resuspending EAT cell pellet in 5-fold
volume of phosphate buffered 0.45% sodium chloride, pH 7.4
and then centrifuged at 250C for 90 seconds at 3000 x g.
The resuspending and centrifuging processes were repeated
until no more erythrocyte contamination was found. Then the
cell pellet was resuspended in known volume of PBS, pH 7.4.
Total cell number was then determined by hemocytometric
measurement. For the stock EAT cells, the viability was
determined by dye exclusion techniques using 0.1% methylene
blue saline. Viability was. always greater than 95%.
3. In vivo test- test for Inhibition
In this series of experiments, 6 mice housed to a cage
were adopted to Purina chow plus supplementary material for
2 days before inoculation with tumour. The supplementary
material was dissolved in distilled water and drunk ad
.UbLtum. Approximately 3 ml solution was consumed each day
by each mouse. Simultaneously, 6 mice supplied with Purina
chow only were used as control. For% inhibition, the mice
were sacrified at day 10 after inoculation, and total
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number of tumour cells were collected and countea as
described previously. For the survival. time studies, the
time of death was recorded.
In vtro test - test for Cytotoxicity4.
The cytotoxicity of the material. was determined by the
method of Beksei (1969) with modifications. Freshly har-
vested 10-day-old EAT cells were utilized. To each test
tube, 1.5 ml solution containing different concentration of
materials in PBS, pH 7.4, was added. The tubes were placed
in the incubation bath (at 250C) for 5 minutes to attain
temperature equilibrium. To each test tube was added 1.5 ml
EAT cells (2 x ]_08). After 2 hours of incubation, the EAT
cells were washed with PBS and then resuspended in 2 ml PBS,
pH 7.4. The viability of the treated and untreated EAT cells
were measured by the dye-exclusion technique using 0.1%
methylene blue as viable stain. Then, 0.2 ml of resuspended
EAT cells was implanted into 6 mice and the total number of
EAT cells developed after 7 days was used to calculated the
transplantibility for the agent used.
Ascites Agar Tube Method5.
The procedure of this test was based on the method
described by DiPaolo and Moore in 1960. Besides methylene
blue, Schiff's reagent -ind toluidin.e blue were also used as
the indicator for cytotoxicity.
Dose Response Study6.
The supplementary materials having significant effect
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on EAT growth were used in this experiment. Various concen-
trations of these materials were supplied to 6 mice as in
the in vivo test. Then, the% inhibition and survival time
were recorded as described previously.
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Results
The result concerning the% inhibition of supplementary materials
on growth of EAT is shown in Table 1. For amino acids, only L-histi-
dine, L-lysine and DL-methionine are likely to exert inhibitory effect
(% inhibition 20%). In the group of monosaccharides, D-fructose
has about 24% inhibition. In group B, only garlic shows significant
inhibitory effect. So, only L-histidine, L-lysine, DL-methionine and
garlic are used for further studies.
The cytotoxicity of the above 4 materials, in in Vit/LO or in
Ascites Agar Tube Method, are presented in Tables 2 to 6. The results
show that L-lysine and DL-methionine are not cytotoxic to EAT but
for L-histidine and garlic, both the in vitAo test and Ascites Agar
Tube Method show that they are cytotoxic.
Furthermore, the dose response of garlic, L-histidine, L-lysine
and DL-methionine on EAT growth are shown in Table 7 and Figures 1 to
3. From the figures, the increase of the concentration of the
materials appear to enhance the inhibitory effect on EAT. The survival
time of different groups of mice are listed in Table 8. All of these
4 materials are able to prolong the length of survival of the EAT
bearing mice. Contrary to% inhibition test, the high dosage (0.5 M)
of L-histidine or L-lysine does not increase the survival time of




Percent inhibition of supplementary material on




DC-Fructose 0.1 M 24 ± 7
D-Mannose 0.1 M 0 ± 0
D-Glucosamine
0.1 M 1± 1
Group B
Decancerlin 1.5 tablet/20 ml
-19±20
Ant icancerlin 1 tablet/20 ml -26± 15
Oldenlandia
1.5 tablet/20 ml -12± 10
Garlic
20 g/100 ml 34± 6




0.1 M 10± 3
L-Glutamine 0.1 M
10±9
L-Histidine 0.1 M 20± 7
L-Lysine
0.1 M 20± 7
DL-Methionine 0.05 M 31± 10
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Table 2
Effect of Garlic on Ehrlich Ascites Tumour Cells
Concentration Relative% Viability
Relative% Transplantibility










2 g/100 ml 50 0
1.5 g/100 ml 91
0




0.05 g/100 ml 91
64




Effect of Histidine on Ehrlich Ascites Tumour Cells
Concentration % Viability
Relative% Transplantibility
0.2M 40 ± 5
4 ± 1




0.05M 97 ± 2 76 ± 2
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Table 4







0.05M 94 5 98 7
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Table 5
Effect of Methionine on Ehrlich Ascites Tumour Celis
Concentration





0.05 M 96 64 10
0.02 M 97 85 12
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Table 6























+ : with inhibition
- : no inhibition
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Table 7
Percent inhibition of various concentrations of supplementary maLeL1d1













0.1 M 20 7
0.25 M 33 9
0.5 M
62 9
0.6 M 81 8
DL-Methionine
0.05 M 31 1
0.1 M 51 8
0.2 M 65 1
Garlic 20 g/100 ml 34 6
40 g/100 ml 41 3
20
Table 8
Effect of supplementary materials on the death
of tumour bearing mice
Supplementary material Concentration




20 g/100 ml 18 days
L-Histidine
0( control) 15 days
0.25 M 21 days
0.5 M 17 days
L--Lysine
0( control) 15 days
0.25 M 20 days
0.5 M 18 days
DL-Methionine
0( control) 15 days








0 .2 .4 .6 .8
Cone. of L-Histidine [M]








0 .2 .4 .6
Conc. of L-Lysine (M)
















As mentioned in the introduction, nutrition has a close relation-
ship with carcinogenesis. By the modification of the quantity and
quality of the nutrients in the diet, change for the incidence of
tumour may be found.
Among the materials screened, the group of monosaccharide is
unlikely to have antitumour effect. Although D -fructose has%
inhibition as high as 24%, it is unbelievable that this common sugar
would play this kind of role in carcirogenesis. For D-mannose and
D-glucosamine, the result shows little promise. In 1977, Gonzalez
and Amos reported that administration of drinking water with 1 mg/ml
D-mannose or D-glucosamine increase the% survivor of the EAT bearing
mice from 40% of control to 72% and 73% respectively. But increasing
the concentration of D-mannose, no enhancing effect was found. How-
ever, for high concentration of D-glucosamine, 3 mg/ml, an abrupt
decrease of% survivor (20%) was observed. In Gonzalez's experiment,
survivor was used as a criterion to estimate the inhibitory effect
of the agents whereas% inhibition is used in our experiments.
Suggested by Patt (1960), the survival time does not necessarily
reflect the course of cell multiplication, but total cell count does.
Since higher dosages of carbohydrates are used in our experiment,
and different criteria is used for the estimation of inhibitory
effect, it may be difficult to compare our results with that of
Gonzalez.
Concerning the result of Chinese medicinal drugs and fresh food,
it is curious that all the drugs, although clinically effective, do
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not exert any effect in EAT system. Since these drugs are said to
cure the cancer of the digestive system, so, EAT, which develops
differently, may not necessarily be suppressed by them. In this
group, garlic which was reported to have antitumour activity (refer
to Introduction), is found to be the most effective material. Refer
to Table 2, garlic appears to be cytotoxic and the critical dose is
2g/100ml. At this dosage, there is a drastic decreases of% viability
(to 50%) and% transplantibili.ty to (0%). This is further confirmed
by the result of Ascites Agar Tube Method (Table 6). Both the
toluidine blue and Schiff's reagent show that the concentration of
garlic at 2g/ 100ml has positive inhibitory effect on EAT. For methy-
lene blue, the critical dose might be 0.25g/100ml. Since in Ascites
Agar Tube Method, the color r•.hange of the dyes indicates the inhibi-
tion on certain specific group methylene blue for dehydrogenase
activity toluidine blue for RNA and Schiff's Reagent for aldehyde
(likely DNA) (DiPaolo and Moore, 1960), therefore, by increasing the
dose of garlic, dehydrogenase activity is firstly observed to be
suppressed, then RNA and DNA therefore the cells die.
Although garlic is found to be an effective material on EAT
growth, its pungent smell make the high-dose administration impossible.
That is why further study of garlic is not carried out.
Among the 5 amino acids screened, although 5% L-arginine
supplemented to diet was reported to retard EAT growth. (Milner and
Stepenovich, 1979), however in Table 1, L-hiss idine, L-lysine and DL-
methionine are found to be more effective.
In dose-response experiment, a linear relationship is observed
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for the three amino acids studied. (Table 7, Fig. 1 to 3) The%
inhibition for L-histidine and L-lysine can reach over 80% at high
dosage. In Table 9, it is found that the EAT mice supplemented with
0.5 M L-histidine have shorter (17 days) survival time than with
0.25 M L-histidine (21 days). The same is observed in L-lysine
treatment. (0.5 M- 18 days, 0.25 M- 20 days). Harper et.al. in
1970 reviewed that excessive ingestion of essential amino acid is
toxic to the animals. As L-histidine, L-lysine and DL-methionine are
reported to be the essential amino acids of mice (Meister, 1965), the
shorter survival time at higher dosages may then relate to excessive
amino acid uptake which is toxic to the animal, although at this
dosage EAT growth.is suppressed significantly.
Refer to Tables 2 to 4, L-lysine and DL-methionine were found
to be non-cytotoxic to EAT cells at 0.2 M and 0.1 M concentration.
This was further confirmed by the :%scites Agar Tube Method. (Table
6) From Table 3, the% viability was observed to decrease from 75%
to 40% as the concentration of L-histidine increase from 0.1 M to
0.2 M. Therefore, L-histidine seems to be cytotoxic but the effect
is rather small compared to garlic.
From the above screening test, L-histidine, L-lysine, DL-
methionine are the most effective antitumour agent in our experiment.
Their actions on EAT cannot be due to their cytotoxicity as they
seems to have little effect on EAT cells themselves. Further experi-
ments are being carried out to find their mechanism.
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Effect of Different Kinds of Foods onPart Two
Ehrlich Ascites Tumour Growth
Introduction
As mentioned before, diet is proposed to be the major factor to
the etiology of cancer. As the three main nutrients in food, the
effects of fat, carbohydrate and protein on carcinogenesis were under
extensive investigation. Animals supplied with high fat diet resulted
in increase incidence of skin tumours induced by different inducers
(Tannenbaum and Silverstone, 1953 Tannenbaum and Silverstone, 1957
Carroll and Khor) 1975) and spontaneous mammary tumours (Tannenbaum,
1942 Lavik and Baumann, 1943 Silverstone and Tannenbaum, 1950
Engel and Copeland, 1951). For dietary protein, animals fed with low
caesin diet had lower incidence of spontaneous hepatoma (Silverstone
and Tannenbaum, 1951b Silverstone and Tannenbaum, 1953), methyl-
cholanthrene- induced leukemia (White et.al., 1947), aflatoxin
induced hepatomas (Wells et.al., 1976), spontaneous mammary carcinoma
and benzyrene induced skin tumours (Tannenbaum and Silverstone, 1953).
However extremely low protein diet was reported to enhance renal
carcinogenesis induced by dimethyl nitrosamine (McLean and Magee,
1970) and to increase the susceptibility to high dose of aflatoxin
in the short term experiments (Madhaven et.al., 1965). Also high
level of dietary protein had been reported to be protective against
some types of cancers, such as p-dimethylaminoazobenzene induced
liver carcinomas (Kensler et.al., 1941 Harris et.al., 1947 Griffin
et.al., 1949) and acetylamino-fluorene induced mammary carcinoma
(Engel and Copeland, 1952). But it also potentiated the formation
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of 3-methylcholanthrene induced mammary tumour and 9,10-dimethyl-1,
2-benzanthracene induced tumours (Walters and Roe, 1964). So, no
generalization can be established. Although the study on dietary
carbohydrate is relatively rare, the administration of different
amount of carbohydrate to animals appeared to affect the development
of certain kinds of cancer, such as Ehrlich ascites tumour (Gonzalez
and Amos, 1977), colon cancer (Wells and Alfin-Slater, 1979).
In order to understand more about diet and carcinogenesis, three
different kinds of foods have been selected. They are margarine,
carnation instant non-fat dry milk and bread. Margarine, a solidified
corn oil, does not contain any protein, carbohydrate, cholesterol but
fat only. For the dry milk, its ingredient is 36% milk protein, 51%
milk sugar and 0% fat. Bread, a common food which contains carbo-
hydrate only, is also used. Instead of Purina chow, these foods are
supplied to the mice in the whole experiments.
As expected, such kinds of food may cause many changes included
underfeeding which is known to suppress carcinogenesis (refer to
General Introduction). In order to distinguish this variation, a
group of mice under restricted diet administration was used as a
comparison. The result shows that the mice under margarine and
restricted diet have essentially the same inhibitory effect on EAT
growth and also the change in body wieghts of the animals are rather
similar.
In margarine treatment, animals were administered with nothing
but fat. This may cause underfeeding. Therefore underfeeding effect
may also contribute partly to its action on EAT. It is stated that
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the starvation can raise the blood ketone body level (Lehninger, 1975.
Eilefson and Caraway, 1976). So, the ketone bodies, acetoacetate and
B-hydroxybutyrate, in blood and ascites fluid were measured. Due to
the rapid glycolysis in EAT cells, hypoglycemia is generally found
in the host (Shapot, 1968). Also, many reports had shown that very
low level of glucose but high content of lactate were found in ascites
fluid (Shapot, 1968). Margarine and restricted diet, both of them
have limited or even no carbohydrate, are expected to alter these two
parameters in blood and ascites fluid.
As both margarine and restricted diet treatments produce approxi-
mately the same % inhibition, survival study was used as a criterion




The food materials were obtained from the following sources:
Mazola margarine from CPC International Inc. (USA) Carnation
instant non-fat dry milk from Carnation Co. (USA) and Life bread
from Garden Co. (Hong Kong).
The chemicals used were of analytical grade and purchased
from different sources: glucose reagent kit, p-nitroaniline,
L-lactic acid, NAD, L-lactic dehydrogenese (rabbit muscle) and
S-hydroxybutyrate dehydrogenase (Rhodops-eudomonas s heroines)
from Sigma Chemical Co. (USA) glycine and ethylacetate from
Merck Chemical Co. (Germany) hydrazine sulfate from BDH
Chemical Co. (England) and Tris (Hydroxy methyl) -methylamine
(iris) from Ajax Chemicals Ltd. (Australia)
II. Methods
Protocol of Experiment1.
The protocol is similar to the in vivo test performed
previously. 12 mice were used as one group. Instead of
Purina chow, margarine, bread and the solution of Carnation
dry milk (10g/100ml) were supplied to different groups of
animals respectively. For the group denoted as restricted
diet, only 1. gm Purina chow was supplied each day. But in
the control, the animals were fed with Purina chow ad
libitum.
After 2 days pretreatment, 6 of the animals in each
group were inoculated with EAT cells (3 x 105) and the
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remainder was used for comparison.
At day 10, the animals were killed by cervical disloca-
tion. Then the EAT, plasma and ascites fluid were collected.
The total number of EAT was measured by using hemocytometer.
Glucose, lactate, acetoacetate and 6-hydroxybutyrate in the
plasma and ascites fluid were assayed. Also, the whole
liver, spleen and right kidney were dissected out and weighed.
In another experiment- survival studies, the time for death
of the animal was recorded.
2. Assay Method for Glucose
The glucose content in plasma and ascites fluid were
determined by using Sigma reagent kit for glucose (Sigma
Technical Bulletin No. 510, 1982).
3. Deproteinization of Ascites Fluid and Plasma
0.5 ml 2 M perchloric acid (HC104) (ice-cold) was added
to 0.5 ml smaple for deproteinization. The solution was
then centrifuged to remove protein precipitate. Supernatant
was then neutralized with 5 M potassium carbonate to pH
about 4 to 6. The solution was then cooled in an ice-bath.
After potassium perchlorate was removed, the supernatant
was stored for lactate, acetoacetate and -hydroxybutyrate
assay.
4. Assay Method for Lactate
The lactate content was determined by the method
described by Gutman (1974). Proper amount of the depro-
teinized sample was added into hydrazine-glycine buffer
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(pH 9.0) containing 2.7 mM NAD. Lactate dehydrogenase
(rabbit muscle) was added to the solution to give the enzyme
activity about 50 units/ml. The mixture was incubated at
25oC for 60 minutes to complete the reaction. The change of
absorbance at 340 nm was assayed by spectrophotometer.
5. Assay Method for D(-)-B-hydroxybutryate
The assay method for D(-) -B-hydroxybutyrate is derived
from the method of Williamson and Mellanky (1965). The assay
solution contains 1.8 ml, 0.1 M Tris buffer, pH 8.5; 1 ml,
1 M hydrazine buffer, pH 8.5; 0.1 ml, 1.3 x 10 -2 M NAD; 0.3
unit of D(-)-B-hydroxybutyrate dehydrogenase in 0.05 ml,
0.05 M phosphate buffer, pH 7.4 and 0.1 ml sample. The
solution was mixed and stand for 60 minutes at room tempera-
ture (25o). By using spectrophotometer, the initial and
final optical densities at 340 nm were measured.
6. Assay Method for Acetoacetate
The method for acetoacetate assay is based on the method
of Wadkins and Lehninger (1963). In this method, 0.5 ml,
1 M acetate buffer (pH 5.7); 0.5 ml sample and 3 ml diazo
reagent were mixed and stand for 40 minutes at room tempera-
ture (25°C). Then 1.0 ml, 5 N HCl was added to stop the
reaction. The above solution was extracted by 4 ml ethyl-
acetate. The absorbance of the ethylacetate layer was
measured at 450 nm by spectrophotometer.
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Results
The percent inhibition of different feeding modes on EAT growth
is presented in Table 1. The administration of margarine or restrict-
ed diet was found to be the most effective in suppressing EAT growth.
For the body weight changes (Table 2), both margarine and restricted
diet show dramatic decrease when compared to the corresponding control
but their difference between each other is comparatively small. The
weights of liver, spleen and kidney are listed in Table 3. The
weight of these three organs in the tumourous control is smaller than
the normal one. Compared to the organs in each corresponding control,
the weight for all treated groups are smaller. The contents of
lactate, glucose, acetoacetate and B-hydroxyb utyrate in plasma and
ascites fluid are tabulated in Tables 4 and 5. The levels of blood
glucose and lactate in tumourous or normal mice are in the order:
control margarine restricted diet. For acetoacetate and
hydroxybutyrate, the one with the highest level is margarine. Except
lactate, the concentration of glucose, acetoacetate or --hydroxybuty-
rate in ascites fluid of the margarine supplemented animal is also
the highest. In survival study (Table 6), the length in each group
is almost the same between the tumourous and normal mice. The time














The body weight change of mice after the administration
of different foods for 12 days
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Table 3
The weight of organs in the mice after 12 days treatment
Liver (gm) Spleen (gm) Kidney (gm)
Control 1.604 0.48 0.164 0.034 0.171 0.014
+EAT
1.428 0.115 0.115 0.026
0.164 0.019
Margarine 1.061 0.168 0.054 0.015
0.130 0.014
EAT 1.074 0.141 0.080 0.030
0.133 0.020
Restricted Diet 0.945 0.079 0.057 0.017 0.139 0.003
+ EAT 0.991 0.136
0.071 0.001 0.146 0.006
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Table 4
The content of blood glucose, lactate, acetoacetate and
B-hydroxybutyr.ate of the mice in different groups
Acetoacetate B-Hydroxybutyrate
Lactate (mM)Glucose (mg/100ml)Groups (umole /ml)(Umole/ml)
I. EAT Bearing
0.80± 0.180.98± 0.167.00± 1.92232.37± 31.41Control
1.85± 0.391.82± 0.114.46± 1.72148.50± 28.07Margarine
Restricted
1.94± 0.481.50± 0.10ND72.43± 14.04Diet
II. Non-EAT
Bearing
ND1.39± 0.157.10± 1.36256.53 19.13Control.
0.39± 0.121.84± 0.111 .05± 0.9106.50± 18.03Margarine
Restricted




The content of glucose, lactate, acetoacecate and B-hydroxybutyrate in
ascites fluid of the EAT bearing mice in different groups
B-Hydroxyb utyrateAcetoacetate
Lactate (mM)Glucose (mg/100ml) (Umole/ml)(umole/ml)
0.27± 0.11151.20± 30.62 0.11± 0.0211.04± 2.34Control
2.42± 0.281 .33± 0.17123.90± 20.3113.63± 3.21Margarine




TH,P mpnn survival time of the mice under different foods administration
Groups
Mean Survival Time (Days)
I. EAT Bearing mice
Control 16± 1
Margarine 14± 1
Restricted Diet 8± 3
II. Non-EAT Bearing mice
Margarine
14± 1
Restricted Diet 9± 3
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Discussion
Many reports suggested that excess dietary fat can promote the
incidences of cancers,, and also different amount of protein, carbo-
hydrate can affect the development of certain cancers (refer to
Introduction). In this experiment,, margarine, dry milk and bread
were supplied as diet to the animals. In our experiment, it was found
that margarine show high EAT inhibition (59%). As the percentage
inhibition is quite similar to that of the restricted diet, it is
proposed that underfeeding may be one of the reason for the fat diet
to suppress the EAT growth. This proposal is further supported by
the data from Table 2. In both the tumourous and normal animals, the
change of body weight for margarine and restricted diet treated groups
was almost the same. Also, the weight is about 10 gram. lower than
the control. The body weight decrease in margarine treated animals
may then be suspected to be due to underfeeding which inhibited the
EAT growth. In order to distinguish between the margarine treatment
from the true underfeeding-restricted diet, further studies were
carried out.
As underfeeding resulted in starvation, the weight of liver,
spleen and kidney of the animals are smaller (Table 3). For the
organs in margarine and restricted diet animals, their weights were
comparable, however lower than the control. The result is reasonable
and also confirms the role of underfeeding in margarine treatment.
When compared the weight of liver, spleen and kidney between the
tumourous and normal controls, curiously, the one for tumourous
control was smaller than the normal one. As mentioned, enlarged
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liver and splenomegaly were found in the animals bearing fibrosacroma
or mammary tumour (Annau et.al., 1951 Begg 1958) this phenomenon
was explained as the results of increased protein anabolism (Yeakel,
1948) and mitotic activity of the liver induced by the tumour (Annau
et.al., 1951). To explain the deviation between this experiment to
the other one, the kinds of tumour used must be considered. Unlike
fibrosacroma and mammary tumour, EAT develops rapidy within the
peritoneal cavity. Although the invasion of the cells is rarely on
liver, spleen and kidney (Wheatley et.al,, 1963), the direct contact
of the tumour cells on the organs may play a role in this size
decrease. Also, the decrease of liver glycogen during tumour growth
(Shapot, 1968) may also explain the weight loss in liver. But none
of these can explain. the phenomenon satisfactorily.
Many had reported that mice bearing EAT developed hyperlipidemia
rapidy (Mermier and Baker, 1974; Brenneman et.al., 1975; Kannan and
Baker, 1975 Ookhtens and Baker, 1979). This lipid abnormality is
mainly hypertriglyceridemia, an increase in VLDL protion in blood
(Brenneman et.al., 1975). The cause of this abnormality is not yet
known. (Begg, 1958) Brenneman et.al. (1975) suggested that the blood
lipoprotein may convert to as the lipoprotein in ascites fluid and
this becomes the fatty acid pool for EAT. Since most fatty acids
from blood were converted to lipoprotein in EAT, resulting in a
shortage of raw material- fatty acids- in the blood, thus reduced
the rate of ketosis. So, as shown in Table 4, the content of blood
acetoacetate and B hydroxybutyrate in tumourous control was lower
than the normal. In the same table, it is shown that the level of
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blood ketone body in margarine treated group is the same between the
normal and tumourous animals. This similarity was also found in the
restricted diet group.
By comparing the quantity of blood ketone body between these
three groups: control, margarine and restricted diet, the level for
margarine was the highest, then the restricted diet and the lowest
one was the control. As starvation was reported to increase the
blood ketone body level (Lehninger, 1975) it is reasonable that the
level of restricted diet was in between the other. two groups. Mar-
garine, besides the effect of starvation, can also supply exogenous
fat to the mice. Although the relationship between the exogeneous
fat to ketosis is still unclear, it is likely that this supply can
enhance ketosis as there is an increase in raw material- fatty acids.
So, it is no doubt that the level of blood ketone body for the
margarine group was the highest. In EAT bearing mice, the high%
inhibition of margarine and restricted diet resulted in reduced
number of EAT cells, so reducing the transfer of lipoprotein from
blood to EAT cells. This is why the blood ketone body in the
tumourous mice was at the same level as the normal mice but higher
than the EAT bearing control.
For the ketone body in ascites fluid (Table 5), the margarine
treated group had its content much more higher than the other two.
(Since the EAT cells cannot utilize ketone body as energy source).
This phenomanon can then be explained as the accumulation of ketone
body derived from blood during the development of tumour. Actually,
the interactions between ketosis and EAT growth is still not knoc.m.
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Thus, the proposed explanations stated are only our predictions.
Besides the induction of hyperlipidemia, EAT growth is also
related to hypoglycemia in the host. By comparing the blood glucose
content depicted in Table 4, the level in tumourous control, as
expected, is lower than the normal, but the difference in blood
lactate is not observed. In Table 5, it is found the blood glucose
and lactate contents of these three groups were in the order as
control margarine restricted diet. The lowest level in restricted
diet may be explained as the restricted intake of total diet by the
mice. The lactate in blood is mainly derived from the glycolysis in
blood cells and muscle (Lehninger, 1975). The insufficiency in
glucose in restricted diet may likely reduce the metabolism of these
cells are thus lower the blood lactate level. As the animals for
restricted diet treatment were observed to be less active than the
control, this physiological change can further support the effect of
insufficient glucose (restricted diet) on the metabolism of muscle
thus resulting in reduction of lactate.
For the margarine treated animals, no glucose is taken, and this
is compensated by the catabolism of the triglyceride administered.
The glycerol backbone of the triglyceride can be converted into
glucose by a series of reactions (Lehninger, 1975). Thus the blood
glucose level of this group is higher than the one in restricted
diet. For a higher blood glucose supply, glycolysis in blood cells
and muscle would be increased. So, the blood lactate was comparatively
higher. Since the metabolism of glycerol can only compensate part of
the glucose required, the blood glucose and lactate in margarine
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group were still lower than the control.
In Table 5, the content of glucose in ascites fluid was very low
with respect to the blood. This result is acceptable as many reports
had shown that the level of glucose in ascites fluid was very low or
zero (Nakamura and Hosoda, 1968; Shapot, 1968). Except the group of
restricted diet, the lactate content in ascites fluid was much higher
than the blood. This result was also agreed to the other publications
(Shapot, 1968). The high lactate but low glucose content in ascites
fluid may due to the high glycolytic rate of EAT (Shapot, 1968). In
case of active glycolysis, the turn-over rate of glucose will increase
and thus lower the level of glucose in ascites fluid. Also, more
lactate will be accumulated in ascites fluid.
From the previous results, it is proposed that margarine admini-
stration not only results in underfeeding but also provides exogenous
fat to the animals. This exogenous fat may work as the energy source.
For the supplementation of extra-energy source, it is thought that
margarine may be better inhibitor for EAT growth. This proposal is
further supported by the result of survival study (Table 6). The
survival time of the margarine treated mice was shown to be nearly
twice as the one of restricted diet. But this treatment is still not
the best. It is because the survival time of the tumourous or normal
mice under margarine administration was still shorter than the
tumourous control. This finding may be due to the physiological
imbalance, such as fatty acid, caused by excessive fat ingestion. In
order to understand more about diets on EAT growth, combinations
should be tried out.
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Part Three The Effect of Ammo Acid Supplementation
on EAT Bearing Mice
Introduction
The relationship between dietary amino acids and cancers was
reviewed in many reports and in previous sections of this thesis.
Based on these reviews, the screening test in. Part I was carried out.
The results showed that the drinking water supplemented with. L
histidine, L-lysine and DL-methionine appeared to inhibit the growth
of EAT and the effect was dose-responsive. In order to understand
more about such kind of interaction, the effect of these amino acids
was further studied particularly their actions on enzyme activities
and their uptakes by various organs. Their effects on blood glucose,
cholesterol and liver, spleen glycogen levels were also investigated.
The study was divided into three different experiments. Experi-
ment I was about the actions of amino acids supplementation on the
activities of different enzymes in different organs of the tumourous
or normal animals. Experiment 2 was to investigate the uptake of
amino acids and nucleosides in the mice. Only L-histidine supple-
mented group was used in experiment 3, of which the levels of blood
glucose, blood cholesterol, liver and spleen glycogen were considered.
Effect of Amino Acids Supplementation of theExperiment One
Enzymes in Different Organs
Many reviews and reports showed that the development of tumour
may alter the activities of certain enzymes in the host, especially
the isozymes (Riley et.al., 1960 Criss, 1971 Weinhouse, 1971
Schapira, 1973 Marshall et.al'., 1979). For example, Herzfeld and
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Greengard (1972) reported that the incidences of Walker 256 carcinoma
and mammary carcinoma DMBA 5A significantly decreased the activities
of ornithine aminotransferase, glucokinase, glutamine synthetase and
malate-NADP dehydrogenase in the liver of the host. Abreu and Abreu
(1978) also showed that Ehrlich ascites carcinoma activated the
activity of liver furmarase but inhibited the aconitase. For the
action of amino acids on enzymes, it was reported that the level of
dietary histidine affected thi, activities of histidine degradation
enzymes in liver (Sahib and Murti, 1969 Kang-Lee and Harper, 1979).
Also, dietary protein content appeared to modify the activities of
urea cycle enzymes in liver (Mandelstam and Yudkin, 1952 Schimke,
1962). This suggests that there seems to be a correlation between
amino acid supplementation and enzymatic activity. In chemotherapy,
some antitumour drugs exerted their effects by altering the activi-
ties of some enzymes. For example, MTX on NAD-ase (Au, 1975) and 6--
thioinosine-5'-phosphate on inosine 5'-phosphate dehydrogenase
(Atkinson et.al., 1963) in EAT cells. To understand more about
enzymatic activities and EAT growth, experiments were performed to
find out:
(1) The enzymic patterns in tumourous and normal mice.
(2) The role of amino acids supplementation on this pattern.
The enzymes selected were based on the following criteria:
(1) Be an isozyme. Isozyme shift defined by Weber (1976) was
found in the cell after transformation. This shift was
supposed to be due to the result of reprogramming of gene
expression in cancer (Weber, 1976). Such kind of shift was
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also reported in other organs during the development of
cancer (Schapira, 1973).
(2) Its activity had been reported to be different between the
tumourous and normal animals. For instance, alkaline
phosphatase, the level of it in human serum increased in
the presence of osteocarcinoma (Bagshawe and Searle, 1977)
lactate dehydrogenase, its activity in serum of mice
increased by 5 to 10 fold in 26 kinds of transplanted or
spontaneous tumours. (Riley et.al., 1960)
(3) The availability of the assay methods in the laboratory.
Dependent on the above criteria, acid phosphatase, alkaline
phosphatase, aldolase, fructose-1,6-diphosphatase, glucokinase,
glucose-6-phosphate dehydrogenase, lactate dehydrogenase and tyrosine
aminotransferase were selected and their activities in liver, spleen,
kidney, small intestine and peritoneal muscle were measured.
The Investigation on the Uptake of the Amino AcidsExperiment Two
and Nucleosides in the Hosts
There are two sections in this experiment. Section one concerned
the uptake of amino acid and section two, nucleosides, thymidine and
uridine uptake. For amino acid uptake, labelled L-histidine, L-lysine
and DL-methionine was mixed with proper amino acid in different
concentration and supplied to the mice intragastrically. The uptake
of individual amino acid at fixed peroid of time was determined. It
was reported that tumour cells had the activity to concentrate amino
acid from the plasma amino acid pool more efficiently than did the
normal cells (Goodlad, 1964). As the content of plasma free amino
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acid pool is partly determined by dietary intake the alteration of
the dietary amino acidAcomposition may affect the concentrative force
of the tumour cells. Also, Norberg and Greenberg (1951), Lundholm
et.al. (1978) and Lundholm et.al. (1979) reported that the liver
from tumour bearing animals incorporated amino acid at a higher rate
in vitno than did the liver from normal controls. The high uptake
rate may relate to the increased hepatic protein synthesis (Lundholm
et.al., 1979). So, the object of the uptake study is to find whether
there is any difference in amino acid uptake between the organs of
the tumourous and normal animals. Also, the effect of the amino acid
load and the chronic effect of amino acid supplementation on this
uptake would be considered.
Section two concerned the uptake of 2 nucleosides, thymidine and
uridine, in the host. EAT cells, as a highly proliferative cells,
may incorporate thi nucleosides more readily. So, the uptake of
these two nucleosides in the host may expect to be different from
the normal ones.
Effect of L-Histidine Supplementation on theExperiment Three
Contents of Blood Glucose, Blood Cholesterol,
Liver and Spleen Glycogen
As mentioned in Part 2, the development of EAT could induce
hypoglycemia in the host. In the case of hypoglycemia, the liver
glycogen content decreased. Other reports also showed that hyper-
cholesterolemia was found in mice implanted with EAT (Begg, 1958).
In 1978, Soloman and Geison suggested that excessive intake of
dietary L-histidine (5% or 8%) could increase the plasma cholesterol
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level and activate the accumulation of liver glycogen in weaning rats
but could not change plasma glucose level. As L-histidine supplemen-
tation appeared to suppress EAT growth, the study was tried to find
out the actions of EAT, L-histidine and both of them, on the four
parameters- blood glucose, blood cholesterol, liver and spleen
glycogen.
It is known that, L-histidine, L-lysine and DL-methionine are the
essential amino acids to mice (Meister, 1965). Nevertheless the
excess ingestion would cause amino acid imbalance which resulted in
growth depression (Harper et.al., 1970). So, in the above experiments,
the body weight changes and the weight of the whole liver, whole




L-histidine hydrochloride, DL-methionine, fructose-l,6--
diphosphate tetra--sodium salt, p-nitrophenolphosphate disodium,
NADP, ATP, NADH, pyridoxal-5' -phosphate, DL-dithiothre itol, D-
glucose-6-phosphate disodium hydrate, 2,5-diphenyloxazole (PPO)
Triton X--100, reagent kit for aldolase, reagent kit for glucose,
glucose-6-phosphate dehydrogenase (Leuconostoc mesenteroides),
phosphoglucose isomerase (yeast) and amyloglucosidase
(Aspergillus niger) were purchased from Sigma Chemical Co. (USA).
Citric acid, tri-sodium citrate, p-nitrophenol, D-glucose,
L-tyrosine, hydrogen peroxide (30%), toluene and glycogen (rabbit
liver) were purchased from BDH Chemical Co. (England)
L-lysine hydrochloride, L-glycine, triethanolamine, MgC12.
6H20, MgS04.7H20, FeC13.6H20, sodium pyruvate, a-ketoglutaric
acid, cholesterol and [2,2'-p-phenylene--bis (5-phenyloxazole)]
(POPOP) were purchased from Merck Chemical Co. (Germany).
(Ethylenedinitri.lo)-tetraacetic acid, disodium salt (EDTA)
and glacial acetic acid were purchased from Mallinckrodt Incor-
poration (USA).
Methyl cellulsolve was purchased from Serva Feinbiochemica
Co. (Germany) and methyl blue from General Chemicals Pharmaceu-
tical Co. (England)
[6-311]-Thymidine (specific activity= 24 Ci/mmole), [5--3H]-
uridine (29 Ci/mmole), L-[4,5-3H]-lysine monohydrochloride (80
Ci/mmole), and L- [methyl-3H] --methionine (89 Ci/mmole) were
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purchased from Amersham International Ltd. (England) L-[3-3H]-
Histidine (10 Ci/mmo.le) was from New England Nuclear Ltd.
(England)
The above chemicals were of anatytical grade.
II. Methods
Maintenance of EAT mice1.
The method was similar to the method described in Part
1. 6 mice with known body weight were adopted to Purina
chow plus drinking water containing various coI.centration
of L-histidine, L-lysine and DL-meth i onine for 2 days. Then
3 of them were inoculated with 3 x 105 tumour cells. The
remainder was used for comparison. Simultaneously, 6 mice
supplemented with Purina chow only were used as control in
the experiment. The mice were administered with the same
supplementation throughout the experiment. At day 10, the
mice were weighed and killed.
Effect of Amino Acid Supplementation on2. Experiment One
the Activities of Different Enzymes
2A Preparation of the homogenates for enzyme assa s
The mice at day 10 were killed by cervical dislocation.
The blood collected was centrifuged for 15 minutes at 3000
x g. The supernatant obtained was denoted as plasma. The
EAT cells was collected as the method described in Part 1.
The EAT cells were resuspended in 0.45% NaC1, pH 7.4. Then,
the swollen cells were disrupted in an ultrasonic disinte-
grator (Brauson Sonic Power, Model S125) and the suspension
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was denoted as EAT cell homogenate. Concomittantly, the
liver, spleen, right kidney, the front portion of small
intestine and the peritoneal muscle were removed and rinsed
in 0.05 M phosphate buffer, pH 7.4. The organs were then
transferred separately into test-tubes containing 4 ml
0.05 M phosphate buffer, pH 7.4 and homogenized by Polytron
(KINEMATICA Type PTA10-35). The homogenates, including
EAT cell homogenates, were they. centrifuged at 10,000 x g
at 4°C for 10 minutes. The clear supernatants obtained
were used for protein determination (Lowry et.al., 1951)
and enzyme assay.
2B Assay methods for enzymatic activities
The activities of eight metabolic enzymes, acid phos-
phatase, alkaline phosphatase, aldolase, fructose-1.6-di-
phosphatase, glucokinase, glucose-6-phosphate dehydrogenase,
lactate dehydrogenase and tyrosine aminotransferase were
assayed. The methods were described in the following:
2B(i) Al.dolase
The activity of aldolase in different organs were
assayed by using the Sigma reagent kit for aldolase (Sigma
Technical Bulletin No. 750, 1981). The activity was
expressed as Umole for fructose-1,6-diphosphate split/min/
mg protein.
2B(ii) Acid phosphatase
The assay method was based on the method of Linhandt
and Walter (1965). 0.2 ml of sample was added to 1 ml acid
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buffer substrate solution (0.05 M citrate buffer 5.5 x
10-3 M p-nitrophenylphosphate pH 4.8) which had equili-
brated at 37°C for 5 minutes. After mixing, the medium
was incubated at 37°C for 30 minutes to complete the
reaction. In order to stop the reaction, 4 mi, 0.1 N NaOH
was added. The absorbance was monitorred by using spectro-
photometer. The activity of the enzyme was then calculated
from the standard curve using p-nitrophenol as standard.
The unit of the activity was umole of p-nitrophenol
liberated/min/mg protein.
2B (iii) Alkaline phosphatase
The method was similar to the one for acid phospha-
tase. Instead of using acid buffered substrate solution,
alkaline buffered substrate solution (0.05 M glycine
buffer 5.5 x 10-3 M p-nitrophenol phosphate pH 10.5) was
used. Also, 5 ml, 0.02 N NaOH but not 0.1 N NaOH was used
to stop the reaction.
2B (iv) Glucokinase
The activity of glucokinase was assayed by the
method of Jamdan and Greengard (1970). The incubation
mixture contained 2 ml, triethanolamine (75 mM) and EDTA
(7.5 mM) buffer, pH 7.6 0.5 ml, 30 DIM MgC12.6H20 0.05 ml,
7.5 mM NADP 0.1 ml, 150 mN ATP 0.2 ml, 1.5 M D-glucose
0.1 unit of glucose-6-phosphate dehydrogenase in 0.1 ml,
0.05 M phosphate buffer, pH 7.4 and 0.1 ml sample. The
mixture was allowed to stand for 20 minutes at room
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temperature (25°C). The 0.05 ml, 2.5 N NaOH was added to
stop the reaction. The absorbance at 340 nm. of each sample
was measured with respect to corresponding blank which
contained same mixture but with the prior addition of NaOH
to the sample. The activity was expressed as change of
absorb ance/min/mg protein.
2B(v) Glucose-6-phosphate dehydrogenase
The enzyme activity was assayed by using the method
of Langdon (1966). The assay medium consisted of 0.1 ml,
1 M Tris buffer, pH 7.5 0.1 ml, 2.5 x 10-2 M glucose-6-
phosphate 0.1 ml, 2 x 10-3 M NADP 0.1 ml, 0.2 N MgC12
2. 5 ml distilled water and 0. 1 ml sample. The absorbance
at 340 nm at time 0, 30, 60 minutes were recorded. The
activity was as: change of absorbance/min/mg protein.
2B(vi) Fructose-1,6-diphosphatase
The method was modified from the method of Ulm and
Pogell (1975). The assay medium contained 2.5 ml, 0.1 M
Tris buffer, pH 7.5 0.15 ml, 0.05 M MgSO4; 0.15 ml, 3.0 M
KC1 0.03 ml, 10 mM EDTA 0.03 ml, 15 mM NADP 0.5 unit of
glucose-6-phosphate isomerase and 0.05 unit of glucose-6-
phosphate dehydrogenase in 0.05 ml, 0.05 M phosphate buffer,
pH 7.4 and 0.1 ml sample. The medium was then mixed and
stand for 1 hour at room temperature. By using spectroph o-
tometer, the optical density at 340 nm was recorded at the
times of 0, 30, 60 minutes. The activity of the enzyme was
expressed as change of absorb ance/min /mg protein.
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2B(vii) Lactate dehydrogenase
The assay for lactate dehydrogenase was modified
from the method of Bermeyer et.al. (1965) 0.05 ml sample
was added to 3 ml assay medium (7.5 mM sodium pyruvate and
1 mM NADH in 0.05 M phosphate buffer, pH 7.4). After
standing for exactly 5 minutes at room temperature, 0.05 ml,
2.5 N NaOH was added for stopping the reaction. By using
corresponding blank, the absorbance at 340 nm of each sample
was recorded. The corresponding blank was the one with the
prior addition of NaOH to the sample. The activity was
represented as: change of absorbance/min/mg protein.
2B(viii)Tyrosine aminotransferase
The method is a fixed time assay which depends upon
the alkali-catalyzed oxidation of p-hydroxyphenylpyruvate
by molecular oxygen to p-hydroxybenzaldehyde and oxalate.
The process was the modified one from Hayashi et.al. (1967).
The reaction mixture contained I mM tyrosine, 9 mM a-
ketoglutarate, 0. I. mM pyridoxal phosphate, 1 mM EDTA, 1 my
dithiothreitol, 90 mM triethanolamine, in a total volume of
2.7 ml, at pH 7.6. The reaction was started by the addition
of 0.1 ml sample and allowed to incubate for 15 minutes at
37°C . With rapid mixing, it was then stopped by the
addition of 0.2 ml, 10.5 N KOH. The absorbance was read
against a reagent blank (consisting of the complete
reaction mixture as NaOH added before the sample) at 331
nm in spectrophotometer. While in calculation, 19,900 M-1
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was used as the effective extinction coefficient of p-
hydroxyphenylpyruvate. The activity was presented as
number of p-hydroxyphenylpyruvate formed/min./mg protein.
Uptake of Amino Acids and Nucleosides3. Experiment Two
in the Host
3A Tracing method for the uptake of radioactive amino
acids
At day 10, 0.2 ml of different concentration of amino
acids- L-histidine, L-lysine or DL-methionine- containing
2 UCi proper amino acids was administered into the mice by
oral intubation. After 4 hours, the mice were killed by
cervical dislocation. The blood, EAT cells, ascites fluid
were then collected. Also, the whole liver, whole spleen,
right kidney, front portion of small. intestine and peritoneal
muscle were dissected out. After rinsing in distilled
water, they were weighed. The organs were then homogenized
in 3 ml distilled water. Sample containing 0.2 ml of
different homogenates, ascites fluid, blood, plasma, EAT
cells was transferred into the counting vial respectively.
Then 0.2 ml 60% HC104 and 0.4 ml 30% H202 were added. The
digestion process was carried out in an oven at 70°C for.
12 hours. After cooling to room temperature, 1 ml methyl
cellulsolve and 7 ml scintillant (18 gm PPO, 1.8 gm POPOP,
1.5 triton X--1.00 and 3 toluene) were added. Then the
radioactivity in each vial was counted by liquid scintil-
lation counter (Beckman LS7000). This tracing method was
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adopted from the method of Mah_in and Lofberg (1966).
Tracing method for labelled nucleosides in animals3B
At day 10, 0.1 nil distilled water containing 2 oCi
radioactive thymidine or u.r:idine was injected subcutaneously
into the animal. After 4 hours, the mice were sacrified
and the process was continued as described in 3A.
Experiment Three Effect of L-Hist.idine Supplementation4.
on the Levels of Blood Glucose, Blood
Cholesterol, Liver and Spleen Glycogen_
After EAT implantation, the mice were sacrified by
cervical dislocation at day 5 to 10. The EAT cells and
plasma were collected. The number of EAT cells was counted
by hemocytometric method and the plasma was used in the
assays for glucose and cholesterol. Simultaneously, the
whole liver and spleen were removed and weighed. The organs
were then stored at -20°C until the measurement of glycogen
content.
4A Method for measurement of plasma glucose
The blood glucose content was measured by using Sigma
reagent kit for glucose (Sigma Technical Bulletin No. 510,
1982)
4B Method for measurement of plasma cholesterol
The method used was derived from the one stated by
Zlatkis et. al. in 1953. 0.05 ml plasma, saline or choles-
terol standard solution (200 mg/100 ml) was added to 2.5
ml glacial acetic acid respectively. Then, 0.2 ml of
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colour reagent, which prepared by adding 10% FeC13.6H20 in
acetic acid into 100 ml concentrated sulphuric acid, was
pipetted into the sample. The solution was mixed vigorously
and stand in running water bath for 10 minutes. By using
spectrophotometer, the absorbance at 560 nm was measured.
The concentration of the cholesterol was calculated as
OD. of the
concentration of cholesterols ampleConcentration
standardOD. of the(mg/ 10Oml)
standard
Method of estimation of liver and spleen glycogen4C
The procedure of th:[s method was based on the method
of Roehing and Allred in 1974. The frozen organs were
homogenized in 5 ml ice-cold distilled water by using
Polytron. Then 0.05 ml homogenates or glycogen standard
solution was preincubated for 10 minutes at 500C with 0.1
ml of 0.05 M acetate buffer, pH 4.5, 3.5 units of amylo-
glycosidase and 0.35 ml distilled water. After the pre-
incubation period the glucose content in the mixture was
analyzed with the Sigma reagent kit. The glycogen content




For experiment one, the activities of acid phosphatase, alkaline
phosphatase, aldolase, fructose-1, 6-diphosphatase, glucokinase,
glucose-6-phosphate dehydrogenase, lactate dehydrogenase and tyrosine
aminotransferase in different organs of the tumourous or normal mice
under L-histidine supplementation are shown in Tables 1 to 8 respec-
tively. From Tables 9 to 16, and Tables 17 to 24, the results for L-
lysine and DL-methionine are also shown respectively. The trends for
the enzymic pattern in the host under amino acids supplementation is
summarized in Table 42. Also, the activities of these 8 enzymes in
the organs of the tumourous and normal controls are summarized in
Figure 7.
In experiment 2, the relative uptake (iCi/gm tissue), the absolute
uptake (pmole/gm tissue) and the total uptake of L-histidine are
depicted from Tables 25 to 27 respectively. For L-lysine and DL-
methionine, their results are shown in Tables 28 to 30 and Tables 31
to 33. The trend for relative uptake and total uptake of amino acids
in the animals are listed in Tables 43 and 44. In Tables 34 and 36,
the results for the effect of amino acids supplementation on the
nucleosides- thymidine and uridine- uptake are presented. For the
total nucleoside uptake in liver, spleen, kidney and EAT cells, the
data are reported in Tables 35 and 7. The trend for the uptake
pattern and total uptake of these two nucleosides are summarized in
Tables 45 and 46 respectively.
For experiment 3, the blood glucose and blood cholesterol level
of the mice under L-histidine supplementation are shown in Figures 1
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to 2 respectively. Figures 3 and 4 depict the relative and total
glycogen and content in liver and Figures 5 and 6 show the content
in spleen. In Table 38, the numbers of EAT cells at day 5 and 10 in
mice under L-histidirie supplementation are also listed.
The change of body weight of the tumourous and normal mice under
12 days amino acids supplementation is depicted in Table 39. Also,
the total and relative weight of liver, spleen and kidney of these
groups of animals are listed in. Tables 40 to 41.
From Tables 42 to 46, the trend is represented by different signs.
As the concentration of the amino acid increased, the patterns for
"I" is no change;
is increasing;
is decreasing;
is firstly decreasing, then increasing;
and is firstly increasing, then decreasing.
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The activity of acid phosphatase in different organs
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TpMP 2
The acitivty of alkaline phosphatase in different organs
of the mice under L-histidine supplementation
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NA : Not available
ND : Not detectable
TaKlo T
The activity of aldolase in different organs of the mice
under L-histidine supplementation
Enzvme A r r i v i t ( nmnl o RFiPA rrn' -n ma nrnfpin 1




















































































NA : not available
The activity of fructose-1,6-diphosphatase in different organs
m -f t In o mi pd nnrlor I —hi c t l H 1 n P Q 1113 H 1 PTTIPH f~ P t 1 O T
P n 7 vmt infiui t~ ( ID r AO.f). min mp nrnfpin
















































































NA : not available
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The activity of glucokinase in different organs of the mice
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NA : not available
Tflhlp 6
The activity of glucose-6-phosphate dehydrogenase in different organs
of the mice under L-histidine. supplementation
__ —
Enzvme Activitv ( 10 J A O.D. min. me protein )
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Table 7
The activity of lactate dehydrogenase in different organs
of the mice under L-histidine supplementation
O.D./ min. mg protein10-2ActivityEnzyme
TumourPlasmaMuscleIntestineKidneySpleenLiverConcentration
I. Non-EAT Bearing
NA4.4± 1 .7140± 16101± 3146± 543± 16103± 230 (control) NA4.7± 1.5146± 4112± 4445± 150± 11112± 390.1 M NA5.2± 2 .2143± 46115± 846±462± 1695± 100.25 M NA6.9± 2.7137± 15123± 2550±172± 26106± 210.5 M NA7.2± 2.1122± 39142± 3850± 877± 1386± 160.75 M
II. EAT Bearing
18± 15.3± 2.9144± 29122± 3659± 1574± 12152± 290 (control) 18± 56.9± 1.0153± 47106± 1647± 272±3132± 440.1 M 17± 137.6± 1.2141± 1383± 1343±572± 23125± 240.25 M 18± 88.4- 6.7148±2778± 2341± 668±4104± 200.5 M 15± 19.5± 2.2148± 3967± 639±665± 16108±300.75 M
NA: not available
Tab 1e 8
The activity of tyrosine aminotransferase in different organs
of the mice under L-histidine supplementation
Enzyme Activity ( ymole p-hydroxyphenylpyruvate min. mg protein)
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TQK1O
The activity of acid phosphatase in different organs
of the mice under L-lvsine supplementation
Enzym Activity ( Umnlp u— ni t rnnhenol min rnc nrotein 1
Concentratioi Liver Spleen Kidney Intestine
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The activity of alkaline phosphatase in different organs
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T „U 1 11
The activity of aldolase in different organs of the mice
under L-lvsine supplementation
F,n zvmf Activity ( pinole FDP min mg protein )
Concentration Livei Spleen Kidney Intestine Muse1g P1xQm
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FDP : fructose-1-diphosphate
NA : not available
To-kl o 1 ?
The activity of fructose-1,6-diphosphatase in different organs
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The activity of glucokinase in different organs of the mice
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Tahlo 1;
The activity of glucose-6-phosphate dehydrogenase in different organ?
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NA : not available
Tab ! p. 15
The activity of lactate dehydrogenase in different organs
of thp mi re under L-lvsine suDDlementation
Enzyme Activity
-2
( 10 A O.D. min. mg protein )
Concentration Liver Spleen Kidnev Intestine Muscle
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T ah1p If
The activity of tyrosine aminotransferase in different organs
nf mi rp under T,~ 1 v.qirip snnnl ementation
Enzvme Activity ( umole p-hydroxvphenylpyruvate min. mg protein )



















































































NA : not available
Table 17
The activity of acid phosphatase in different organs
l-Vso mi no nnrlor nm'np q i inn 1 pmPn t £1 t~ i nri
F,n 7vmp Activity ( pinole p-nitrophenol min mg protein ]



































































NA : not available
n IP
The activity of alkaline phsophatase in different organs
of the mice under DL-methionine supplementation
Enzyme Activity ( ymole p-nitrophenol min mg protein )



































































NA : not available
Table 19
The activity of aldolase in different organs of the mice
under DL-methionine supplementation
Enzvme Activity ( umole FDP min mg protein )
Concentration Liver Spleen Kidney Intestine Mil Q C 1 P



































































NA : not available
Trhlr ?(
The activity of fructose-1,6-diphosphatase in different organs
of the mice under DL-methionine supplementation
Enzvme Artivitv
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NA : not available
ND : not detectable
TaMp 9 1
The activity of glucokinase in different organs of the mice
under DL-methionine supplementation
Enzyme Activity ( 10 Ann nn' n mrr nrnfoi n
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Table 22
The activity of glucose-6-phosphate dehydrogenase in different organs
of the mice under DL-methionine supplementation
Enzyme Activity ( 10 A n n rm'n mo- nrntPin




































































NA : not available
T-sh 1 p 23
The activity of lactate dehydrogenase in different organs
of the mice under DL~methionine supplementation
Enzyme Activity
_2
( 10 A fl.H. min. me nrotein )




































































NA : not available
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Table 24
The activity of tyrosine aminotransferase in different organs
of the mice under DL-rnethionine supplementation
Enzyme Activity ( umole p-hydroxyphenylpyruvate/ min,/ mg protein)
Concentration Liver
Spleen
kidney Intesti Muscle Plasm Tumour
I. Non-EAT Bearing
0 (control) 16.9 5.2 2.6 0.5 5.8 1.0 1.1 0.4 1.8 1.0 0.34 0.10 NA
0.05 M 34.0 1.2 2.3 0.3 5.1 1.4 1.5 0.5 1.3 0.4 0.20 0.02 NA
0.1 M
35.5 9.7 2.3 0.3 4.3 0.0 1.6 0.6 1.7 0.4 0.19 0.01 NA
0.1 M
44.5 10.5 2.3 0.4 3.7 0.8 2.4 0.8 1.5 0.5 0.20 0.02 NA
II. EAT Bearing
0 (control) 24.5 6.2 2.0 0.8 7.8 1.2 0.8 0.3 1.3 0.3 0.39 0.10 5.8 3.3
0.05 M
30.8 5.4 2.3 0.5 7.6 1.8 1.2 0.4 1.2 0.3 0.27 0.04 4.3 1.6
0.1 M
39.6 10.4 2.1 0.3 7.2 1.9 1.3 0.6 1.2 0.4 0.21 0.04 5.0 1.3
0.2 M
79.2 13.7 2.6 0.4 3.5 1.6 1.3 0.4 1.4 0.4 0.22 0.09 5.2 1.6
NA : not available
Table 25A
Relative uptake of L~C3-HJ3-histidine in the mice without L-histidine supplementation
Relative Uptake ( nCi gm tissue )









































































































The unit is nCi ml.
!The unit is nCi109 EAT cell
Ascites fluid
NA : not available
Relative upatke of L-C3-H3J-histidine in the mice with L-histidine supplementation
Relative Uptake ( nCi 2m tissue )
Concentratior Liver Spleer Kidney Tnfpcfinp Mi is r 1 p Plasm, R 1 rn


































































































The unit is nCi ml.
Te unit is nCi 10 EAT cell
Ascites fluidA w J.
NA : not available
T aK 1 o 9 f A
The absolute uptake of L-histidine In the mice without L-histidine supplementation
Ah.c;nl nf e Uptake ( 10 P mole gm tissue )
Concentratior
i 1






















































































The unit is 101 pinoleml
n The unit is 101 pmole109 EAT cell
Ascites fluid
NA : not available
The absolute uptake of L-histidine in the mice with L-histidine supplementatioi
Absolute TT-nf~ ( 10 u mole em tissue )
Concentration Liver Spleen Kidney Intestine MiicpI c
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The unit is 101 ymoleml
The unit is 101 umole'109 EAT cell
Ascites fluid
NA : not available
Table 27A
f
Total uptake of L-histidine in the mice without L-histidine supplementation
Total Untake
Liver SDieen Y -f A -n EAT Cell



























































































Total uptake of L-histidine in the mice under L-histidine supplementation
Total TTr f oVP
Liver Spleen Kidney
n at Pa1 1






















































































NA : not available
f Radioactive L-histidine
Relative uptake of L-C4,5-H33-lysine in the mice without L-lysine supplementation
R p 1 a t i v IT n t a Vt ( nCi cm tissue )




















) 71 ± 3
7 73 ± 12
















































































The unit is nCi ml
n The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
Relative uotake of L-T4 .5-H3]-lysine in the mice with L-lysine supplementation
Re la' ive TTrf- r ( nCi em tissue )
Concentratioi Liver Snlee Kidney Tnlnolini Mi i s r 1 f
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) 117 ± 16
) 96 ± 37
f 96 ± 4
: 113 ± 55




































! The unit is nCi mln
13 The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
Table 29 A
The absolute uptake of L-lysine in the mice without L»lysine supplementation
Absolute Uptake ( 10 umole em. tissue )
Concentration Liver Spleen Kidney Intestine Muscle
51
Plasma '



















































































The unit is 10--1- pinoleml
P| The unit is 101 ymole109 EAT cell
Ascites fluid
NA : not available
Table 29B
The absolute uptake of L-lysine in the mice under L-lysine supplementation
Absolute Uptake ( 10 ymole gm tissue )
Concentration Liver Spleen Kidney Intestine Muscle
A






















































































The unit is 10_1 ymoleml
The unit is 10-1 yinole105 EAT cell
Ascites fulid
NA : not available
T oK1 o THA
Total uptake of L-f4,5-H3}-lysine in the mice without L-lysine supplementation
Total Uptake
Liver Snleen Kidnev TP AT Poll






















































































NA : not available
Table 30R
rv
Total UDtake of L-r4.5-Hlysine in the mice supplemented with L-lysine
Total Unt ake
Liver Spleet Kidney VAT Pol 1






















































































NA : not available
Table 3LA
Relative uptake of L-[methyl-H3J-methionine in the mice without DL-methionine supplementation
Relative Uptake ( nCi gm tissue )
Concentration Liver Spleen Kidney Intestine Muscle Plasma51



















































































The unit is nCi ml.
13 The unit is nCi 109 EAT cell
Ascites fluid
NA : not available
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5 73 ± 21
97 ± 3





























































The unit is nCi ml
The unit is nCi 105 EAT cell
Ascites fluid
NA: not available
T ph 1 p 1 ? A
The absolute uptake of DL-methionine in the mice without DL-methionine supplementation
Absolute Uptake ( 10 umole p-m tissue )
Concent rati or Liver Spleer Kidney Intestine Mi iqpI a Plasma
O LIv_ J






























































The unit is 101 pinoleml
11 The unit is 101 pinole109 EAT ceil
Ascites fluid
NA : not available
Table 32 E
The absolute uptake of DL-methionine in the mice with DL-methionine supplementatior
Absolute Uptake ( 10 Limole cm tissue )
Concent rati or Live i Splee Kidney Intestine Mi is c 1 p PI a o m




























































The unit is 101 pinoleml
The unit is 101 ymole109 EAT cell
Ascites fluid
NA : not available
Table 33A
Total uptake of L-pnethyl-Hp -methionine in the mice without DL-methionine
fiimn1pmentation
Total Uptake
Liver Spleei Kidney KAT Cell




































































NA : not available
Table 33E
Total uptake of L-£methyl-H33-methionine in the mice supplemented with DL-methionine
Total TTrt o1 r c
T.i vpr V T rl n 7 r AT Pa! 1
Concentration yCi ymolc uCi umole i mc 1 rs



































































NA : not available
ToKlo 1AA
Relative uptake of £6-H3]-thymidine in the mice under L-histidine supplementation
Relative Tint ake ( nCi vm tissue )
Concentration Live] Snleer Kidne Tnfocfint Mnccla
LlbbUC
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The unit is nCi ml
n The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
Table 34 I
Relative uptake of £6-H3]-thymidine in the mice under L-lysine supplementatior
RPIAt: iv£ T T n t n V£ 0 . •
Concentratior Live i Snleer Kidnev T n f .o cf 1 no



























































































I 26 ± 5
! 24 ± 8
' 24 ± 8





The unit is nCi ml
The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
Table 34C
Relative uptake of C6-H3J -thymidine in the mice under DL-methionine supplementation
Red a t ivp Uptake ( nCi em tissue )
Concentration Liver Spleen Kidney TntPfitinf Muscle P 1 QTTZ



















































































The unit is nCi ml
71 The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
TPM A 3
Total uptake of rb-H'3-thymidine in the mice supplemented with amino acids
Total Uptake
NTr T~ma Ayf1-»s~ i i i rr onTAii XT
Amine
Acids tnn r . T.I'UPT i ] n n

































































































T aK 1 o L
Relative upatke of f5-H33-uridine in the mice under L-histidine supplementation
Rp1pfiVP Uptake
• , •
Concentration Live Spleei Kidne
T r f n c t i n c- Muscle





































































































The unit is nCi ml




Relative uptake of f5-H3]-uridine in the mice under L-lysine supplementatior
Relative TTr t r i ( nCi cm tissue )








































































































The unit is nCi ml
The unit is nCi 10 EAT cell
Ascites fluid
NA : not available
Relative uptake of [ 5 ~H -uridine in the mice under DL-methionine supplementatio
Rp1 ativf
• A A
Concentration Live Spleei K1 d n p
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The unit is nCi ml




Tnt-1 nni-akp of V37-nridine in the mice suDDlemented with amino acids



































































































Percent inhibition and numbers of EAT cells in the mice under
L-histidine supplementation




































The body weight change of normal and tumourous mice














































The weight of whole liver, spleen and right kidney of the mice
for rrnnn ani rl q qi inn 1 pmpn t~ P) f1 DTl
Non-EAT Bearing Mice PAT R o a rin a Mi op
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n 1 o 4- n no
T U 1 , 1
The relative weight of liver, spleen and kidney of the mice after
amino acids supplementation
Relative Weight of Organ TOO rym TTnlrAt- A
Nnn-F.AT Rpprinp Mi rp P AT M 4
Amino Acids Cone .


















5 .40 ± 0.41
6.04 ± 0.4:
5.78 ± 0.4:






































, o q 4- n , £
4.13 ± 0.21
4.18 ± 0.71
A 9 3 + n 6 A
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Table 42
The summary of the trends of enzymic patterns in different organs of
of the mice under amino acids supplementation




Liver Spleen Kidney Intestine Muscle Plasma Tumour



































































_For explanation, refer to Results
The result not expected
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Trend of total uptake of labelled amino acids in mice
Amino Acids Supplementatior
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Trend of relative uptake of labelled nucleosides in the mice
c11-nn 1 pmpn f-prl th aminn api'dfi









rpt N T N T N
ss t:
T 1 T

























T ah 1e 46
Trend of total uptake of labelled nucleosides ( thymidine, and uridine ) in the mice
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and normalFigure 7 The enzymic patterns in the tumourous
controls. The unit of acid phosphatase( AcP)
and alkaline phosphatase( A1K) is umole p-nitrophenol/
min./mg protein aldolase( Ald) is mole fructose-1,
6-diphosphate split/ min./ mg protein fructose-1,
6-diphosphatase( FDP) is 10-2x O.D./ min./ mg
protein glucokinase( GK) is 10-2 x O-D./ min./
mg protein glucose-6-phosphate dehydrogenase( GPDH)
is 10-2 x O.D./ min./ mg protein lactate dehydro-
genase( LDH) is O.D./ min./ mg protien tyrosine
aminotransferase( TA) is Umole p-hydroxyphenylpyruvate/
min./ mg protein.
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Figure 8 The relative uptake pattern of amino acids in
controls.and normaltumourous
L: liver S: spleen K: kidney I: small
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Figure 9 Total uptake( uCi) of amino acids in tumourous
and normal controls
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Figure 10 Relative uptake pattern of nucleosides in tumourous
control.and normal
L: liver; S: spleen; K: kidney ;I: small
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Figure 11 Total uptake( uCi) of nucleosides in tumourous
and normal controls.














Effect of Amino Acids Supplementation on EnzymicExperiment One
Pattern
From Figure 7, the development of EAT was found to elevate the
activities of these enzymes except alkaline phosphatase in kidney
and plasma, aldolase in muscle and plasma, fructose-1,6-diphosphatase
in small intestine, glucose-6-phosphate dehydrogenase in liver and
tyrosine aminotransferase in liver, spleen, small intestine and
muscle in which activities were declined. For lactate dehydrogenase,
this elevation in activity agreed to the experiments of Fountain et.
al. (1970), Riley et.al. (1960) and Riley and Wroblewski (1960). For
alkaline phosphatase in liver and kidney, tyrosine aminotransferase
in kidney, elevated activities were observed and agree with that
reported in the experiment in Kojima and Sakurada (1976). As
compared to other tumours, liver aldolase, glucokinase in EAT bearing
mice are elevated. This is similar to results obtained from the one
bearing mammary carcinoma DMBA 5A (Herzfeld and Greengard, 1972). In
serum, acid phosphatase was increase and this agreed with the results
from prostate carcinoma (Knox, 1967)
The administration of 0.3% DL-methionine in diet was reported to
activate glucose-6-phosphate dehydrogenase in liver but die not have
any effect on lactate dehydrogenase (Yamada, 1977). Also, in in
vitAo test 5 L-histidi_ne was reported to suppress the activity of
intestinal alkaline phosphatase (Bodansky and Schwartz, 1963).
Consistent results like above are shown in Table 42.
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In Table 423, with a few exceptions, the trends for enzymic
patterns are either (1) not changed, (2) increasing or (3) decreasing.
The change varies with the kinds of amino acids, enzymes and organs
considered. For the enzymes which are activated by EAT growth, the
decrease in total cell number resulted from amino acids supplementa-
tion may tend to suppress this activating effect. So, the enzymic
pattern of the tumourous mice under amino acids supplementation may
have the following trends:
If the amino acid did not have any effect on the enzymatici)
activity, the activity will decrease as the increase of
the dose supplied which suppress EAT growth.
If the amino acid can suppress the activity of enzyme, byii)
summing up the effects of EAT growth and amino acid
supplemented, the pattern would decrease much more signifi-
cantly.
If the amino acids supplemented activate the enzymaticiii)
activity, the result will be rather complicated. Dependent
on the degree of activation, the trends would be no change,
gradually increased then decreased or gradually decreased
then increased.
But for the enzymes which are suppressed by EAT growth, the trends
would be different:
i) If the amino acid did not exert any effect, the pattern
would be an increasing one.
ii) If the amino acid exhibit activating effect, a prominent
increasing pattern may be found.
144
iii) For the suppressive action of am-i_no acid, the pattern would
then be more complicated.
All the above, expectations were based on the assumptions that
the amount of amino acid uptake by the organs did not have signifi-
cant difference between the tumourous and normal mice. Also, the
results of the interactions between the amino acids and EAT (e.g.
inhibitory effect of amino acid on EAT growth) have no influence on
the individual effects on enzymatic activities.
From Table 42, acid phosphatase, lactate dehydrogenase and
fructose-1,6-diphosphatase are agreeable to the expectation. For the
other five enzymes, the trends cannot be generalized. As the results
in experiment two suggest that the uptake of amino acid between the
tumourous and normal animals did not have significant difference, it
may be suggested that the interactions between amino acids and EAT
are responsible for the complexity in the trends for alkaline
phosphat ase, aldolase, glucose-6-phosphate dehydrogenase, glucokinase,
and tyrosine aminotransferase.
Concerning the enzymes in EAT cells, the effect of these three
amino acids on them are rather complicated. In the case of gluco-
kinase, they exhibit a stimulating effect while for other enzymes
they either inhibit or show no effect. Due to the complexity of the
response, therefore, whether the inhibitory effect of amino acids
supplementation is directly on these eight enzymes in EAT cells still
cannot be clarified.
Effect of Amino Acids Supplementation on theExperiment Two
Uptake of Amino Acids and Nucleosides
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The result for the uptake study was expressed as relative uptake
(uCi/gm tissue), absolute uptake (umole/gm tissue) and total uptake
(uCi or mole). As the amount of radioactivity admitted and the time
are constant, the relative uptake means the relative attractive force
to the labelled compounds per unit weight of different organs.
Absolute uptake is the product between relative uptake value and
number of umole of the compound admitted. This value means the
actual amount of the compound intake by the unit weight of the organs.
As concerning the whole weight of the organ other than the unit weight
of the organs, the implication of total uptake in terms of uCi and
umole are similar to the relative and absolute uptake values respec-
tively.
Amino Acid UptakeSection A
The pattern for relative uptake of L-histidine, L-lysine and
DL-methionine between tumourous and normal controls is summarized in
Figure 8. The incorporation of L-histidine in spleen and blood is
higher in the normal but in small intestine, the higher one was the
tumourous mice. Also similar values are shown for the other organs,
liver, kidney, muscle. Except the peritoneal muscle and blood which
have smaller uptake value, the other organs of the tumourous animals
exert stronger incorporation force for L-lysine than the normal. The
incorporation of DL-methionine in small intestine is lower in tumourous
animals in blood, there is no change but higher for the other organs.
The high incorporation rate of L-lysine and DL-methionine in the
liver of tumourous mice is consistent with the result obtained from
the mice bearing methycholanthrene- induced Sarcoma (Lundholm et.al.,
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1979). The total uptake (pCi) of these three amino acids in also
presented in Figure 9. Except the uptake of DL-methionine and L-lysine
in liver, the total incorporation of the amino acids in the organs in
the normal mice is higher than the tumourous one. This high incor-
poration may relate to the larger size of the organs in the normal
control. For liver, the high relative uptake value for L-lysine and
DL-methionine in the tumourous control may compensate the effect of
size decrease, therefore, the total uptake of L-lysine and DL-methionine
in liver is still higher than the normal one.
Comparing the relative uptake of L-histidine and L-lysine (Tables
25, 28), the incorporation rate of small intestine is the highest and
there is no other difference among the other organ:. The highest
rate in small intestine is suspected partly by contamination as the
radioactive load was passing through this region into the blood. For
DL-methionine, besides small intestine, the incorporation in liver
appear to be -he second highest one. For the total uptake within
liver, spleen, kidney and EAT cells (Tables 27, 30, 33), the order is
liver > EAT cells > kidney > spleen. As amino acid after intestinal
absorption is firstly transported to liver via the blood and dispersed
to other tissues (Lehninger, 1975), therefore, as expected the total
uptake in liver is the highest. Since EAT cells concentrate amino
acids more efficiently than other normal cells (Goodlad, 1964) there-
fore, it is reasonable that the total uptake of it is rather high.
While comparing the relative uptake in the mice with or without
amino acid supplementation, except EAT cells, it is unlikely that
each corresponding pair would have significant different between
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each other. The incorporation in EAT cells from amino acid supplemen-
ted mice is higher than the one without supplementation, i.e. amino
acid supplementation may enhance the uptake process in EAT cells.
In Table 43, the trend for relative uptake of amino acids is
listed and there is no generalization among the trends. As to cor-
relate amino acid supplementation to relative uptake trend in EAT
cells, it is found that the amino acids supplementation built up an
increasing trend which is not found in the one without supplementa-
tion. This further suggests that the inhibition of amino acid sup-
plementation on EAT growth may relate to its enhancing effect on
amino acid incorporation in EAT cells.
No matter the relative uptake trend is, from the result of
absolute uptake pattern in Tables 26, 29, 32, the actual content of
amino acid incorporated in each organ increase as the load increases.
Except EAT cells, there is no significant difference in the amount of
amino acid uptake by each corresponding organ whether with or without
amino acid supplementation to the mice. For EAT cells, the actual
amount of amino acid intake is significantly higher in the one sup-
plemented with amino acid. This further proves that the inhibitory
effect of amino acid is on the amino acid incorporation in EAT cells.
For total amino acid uptake (Table 44), the trend for total
relative uptake (uCi) in liver, spleen, kidney and EAT cells are also
complicated as the relative uptake pattern and the total absolute
uptake is in increasing manner as the absolute uptake.
Nucleosides UptakeSection B
Since EAT cells is highly replicative, it is expectea tnat the
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uptake of nucleoside (thymidine and uridine) in animal may be altered
by the development of tumour. From Figure 10, except the spleen which
rate becomes higher, the growth of EAT appears not to affect the
relative uptake pattern in the mice while in Figure 11, the total
uptake was slightly higher in the normal control. This may be ex-
plained as due to the larger organ size in the normal control (Tables
40) 41). The same as the control, this observation is also found in
the tumourous and normal mice which are supplemented with amino acids.
For the relative uptake of thymidine in the animals supplemented
with L-histidine, L-lysine or DL-methionine, higher values were
observed in small intestine, peritoneal muscle and spleen and there
is no difference among the others. (Table 34). The rapid prolifera-
tion in intestinal epithelium (Rhodin, 1974) and lymphocytes in
spleen may result in the high level of labelled thymidine in these
two organs. Since the radioactive nucleoside was applied subcutane-
ously, then it is reasonable that the radioactivity would concentrate
more in the peritoneal muscle.
The relative uptake pattern for uridine is similar to thymidine
except the value in spleen is same as other organs and the order of
total nucleosides (thymidine and uridine) uptake is liver > EAT cells
> kidney > spleen.
For the effect of amino acid supplementation on the relative and
total nucleosides uptake, complicated trend is shown in Tables 45 and
46 and no generalization can be given. It is very curious that the
relative uptake by EAT cells for both thymidine and uridine has
increased but there is a decrease in total uptake as increasing the
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concentration of the amino acids supplemented, This result may
relate to the inhibitory effect of amino acids on EAT cells. As due
to the decrease in cell number, although the relative uptake value
increased, the total. uptake would then decrease. Rapid nucleosides
incorporation (relative uptake) always means the cell is highly pro-
liferative, this means high DNA synthesis. Since amino acid supple-
mention retards EAT growth, it is unexpected the amino acid would
promote nucleosides uptake in EAT cells. As mitosis involves a
series of complicated reactions, e.g. DNA synthesis, cytoplasmic
division, etc. and be affected by many other factors, e.g. energy
supply (DeRobertis et.al., 1975), so, maybe the action of amino acid
is on the processes other than DNA synthesis which also exert inhibi-
tions on EAT growth.
Effect of L-Histidine Supplementation on BloodExperiment Three
Glucose, Blood Cholesterol, Liver and Spleen
Glycogen Levels
The effect of L-histidine supplementation or the effect of EAT
growth on the levels of blood glucose, cholesterol, spleen and liver
glycogen had been reviewed in Introduction and the results are shown
from Figures 1 to 6. Firstly, the change of EAT cell number during
L-histidine supplementation will be discussed. From the result in
Table 38, it is shown that L-histidine supplementation appears to
affect the EAT growth at the.early stage after implantation. It was
because the% inhibition at day 5 of each L-histidine treated group
was slightly higher than the% at day 10. This may be explained as
the adaptation of EAT cells to L-histidine treatment. For the blood
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glucose level shown in Figure 1, the gradually declined curves, suggest
that L-histidine administration results in slight hypoglycemia in
normal mice. As EAT growth also induced hypoglycemia (Shapot, 1968),
so, it is not curious that the curves for EAT mice under L-histidine
supplementation shows a more drastic decrease in blood glucose level
than the normal animals. This result is similar to the one obtained
from weaning rats. (Soloman and Geison, 1978)
Unlike weaning rat (Soloman and Geison, 1978), the blood choles-
terol level in mice supplemented with L-histidine does not show any
significant change as shown in Figure 2. This contradictory response
may be due to the differences in the dose of L-histidine and animals
species used. This explanation was also suggested to explain why the
long term oral administration of L-histidine to patient with rheumatoid
arthritis showed no change in serum cholesterol concentration (Soloman
and Geison, 1978). For the effect of EAT growth, it was found that
the level of plasma cholesterol increase dramatically from day 5 to
day 10 in tumourous control and such kind of elevation was also
reported from the experiment of Brenneman et.al. (1975). For the
tumourous group supplemented with 0.1 M L-histidine, such kind of
elevation was also found but not in the groups of 0.25 M and 0.5 M.
This may be due to the retarded growth of EAT in 0.25 M and 0.5 M
groups.
The relative and total liver glycogen are reported in Figures 3
and 4. For the normal mice under L-histidine supplementation, the
level of relative and total liver glycogen decreases just after L-
histidine administration. The extent of decrease is control 0.1 M
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> 0.25 M 0.5 M. The result is opposite to the one in weaning rat,
of which accumulation of liver glycogen was found (Soloman and Geison,
1978). As reported, EAT growth induced hypoglycemia which caused the
destructions of liver glycogen (Shapot, 1968). This action is also
true while comparing the liver glycogen content in the tumourous and
normal control. As both of the EAT growth. and L-histidine supplemen-
tation cause depression in liver glycogen, the mice under these two
treatments are expected to show a larger decrease as compared to the
corresponding normals. This proposal can be confirmed by the results
in Figures 3 and 4.
The relative and total spleen glycogen content are depicted in
Figures 5 and 6 respectively. In normal mice the data of relative
spleen glycogen content suggests that L-histidine does not exert any
effect on the relative content as the range is betwen 5 to 5.50 g/gm
tissue. But the result of total spleen glycogen content shows some
suppressive effect. The decrease in the size of spleen during L-
histidine supplementation is shown in Tables 40 and 41. Therefore,
the decrease in size accompany with the suppressive effect of L-
histidine on the accumulation of spleen glycogen may contribute to the
constant level of relative spleen glycogen. The results in Figures 5
and 6 also agree that in the presence of EAT, the spleen glycogen in
mice under L-histidine supplementation was at a lower level than
each of the corresponding normal. So, similar to the effect on liver,
EAT growth can also induce glycogen destruction in spleen.
Experiment Four Toxicity of Amino Acids on Mice
L-Histidine, L-lysine and DL-methionine are the essential amino
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acid to mice (Meister, 1965) but the excessive ingestion. of these
amino acid resulted in growth depression (Harper et.al., 1970).
Therefore, in the above three experiments, the body weight change and
the mass of liver, spleen and kidney were recorded and presented in
Tables 39 to 41 respectively. In Table 39, body weight change was
observed in the mice supplemented with amino acids. While comparing
the change at 0.25 M L-histidine, 0.25 M L-lysine and 0.2 M DL-
methionine, DL-methionine appeared to be the most toxic one as
reported previously. (Harper et. a_t., 1970) Also, the data for L-
histidine and L-lysine suggests that the dose over 0.5 M would become
toxic to the animals. This suggestion explains the survival studies
in Part 1 that the survival time of EAT bearing mice under 0.5 M amino
acid supplementation was shorter than the one with 0.25 M. For
further confirmation on the toxicity of amino acids, the total and
relative weight of liver, spleen and kidney were measured. Comparing
the size of organ between the tumourous and normal control, the size
in the normal mice is larger than the tumourous one. For the effect
of amino acid supplementation on the organ size, only the data for
non-EAT bearing mice would be discussed. Except the data for relative
liver weight, L-histidine at high dose supplementation was found to
suppress the sizes of liver, spleen and kidney. This exception may
relate to the significant decrease in body weight. The liver size
decreased in this experiment is contradictory to the result on
weaning rat (Soloman and Geison, 1978). In weaning rat, accumulation
of liver glycogen was used to explain the hepatomegaly induced by L-
histidine supplementation (Soloman and Geison, 1978). In this
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experiment, hepatoineraly was also observed in the mice at low concen-
tration of L-histidine (0. 1, 0.25 M) but counteracting with the toxic
action as increasing the concentration of. L-histidine, the size would
then decrease. For spleen size depression, the possible explanation
is that L-histidine appears to suppress glycogen accumulation in this
organ. This proposal was confirmed by the results in Figures 5 and
6, and the relation had mentioned in Experiment Three. In L-lysine
supplemented group, decrease in the size of liver and spleen, and no
change in kidney was observed. For the narrow range of the dose used,
the toxic effect of DL-methionine was not prominent as indicated by
the size change.
Although the two parameters, body weight and organ size, indicate
that high dosages of amino acids was toxic, the role of amino acid on
tumour may still be important. It was suggested that the toxicity of
these amino acids can be reduced by the concomittant ingestion of
other amino acids, for example, L-glycine and/or L-arginine. (Harper
et.al.., 1970) So, besides further studies on the antitumour actions
of these amino acids, the work about the antitumour character of the
amino acid mixture which is less toxic should be carried out.
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Sumary
The findings in this project are:
Pant One
From the screening test, only garlic extract, L-histidine, L-1.
lysine and DL--methionine are suspected to be the valid anti-
tumour agents.
Garlic extract is cytotoxic to EAT cells but the amino acids2.
are not.
Punt' Two
Margarine and underfeeding (restricted diet) are found to exert1.
high% inhibition on EAT growth.
The influences of margarine treatment on the levels of glucose,2,
lactate and ketone body in blood and ascites fluid are
different from underfeeding.
From the survival study, margarine treatment is more preferred3.
than underfeeding in the cure of EAT.
EAT growth can induce hypoglycemia and lower the blood ketone4
body level.
The level of glucose in ascites fluid is very low but high in5. .
lactate content.
The level of blood ketone body in both tumourous and normal mice6.
is in the order as: margarine > restricted diet > control; and
the one for blood glucose and lactate is control >margarine>
restricted diet.
Pant Thnee
In general, EAT development activates the activities of aldolase,1.
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acid phosphatase, alkaline phosphatase, fructose-1,6-diphosphatase,
glucokinase, glucose-6-phosphate dehydrogenase, lactate dehydro-
genase and tyrosine aminotransferase in different organs.
The interactions between the amino acids and EAT cells may alter2,
their influences on alkaline phosphatase, aldol.ase, glucose-6--
phosphate dehydrogenase, glucokinase and tyrosine aminotransferase
but not on acid phosphatase, lactate dehydrogenase and fructose-
1,6-diphosphatase.
The correlation between EAT growth and uptake patterns of aminoI
acids and nucleosides cannot be generalized.
Except EAT cells, amino acids supplementation seems not to affect4,
the relative and absolute uptake of amino acids in different
organs.
The increasing trend for the relative uptake of amino acids in5
EAT cells which originated from amino acids supplemented mice
suggests that the inhibitory effect of amino acids on EAT growth
is probably due to the increase in incorporation process for
amino acid in EAT cells. This is Further supported by the result
of absolute uptake.
No matter the relative uptake pattern is, the absolute uptake6,
trends in different organs increase while the concentration of
amino acids increase.
Except EAT cells, the trend for nucleosides uptake is not7.
affected by amino acids supplementation.




L-Histidine may exert its effect on EAT growth at the earlier9.
stage of ter implantation.
L-Histidine does not affect the blood cholesterol level but EAT10.
growth elevates this level dramatically from day. 5 to 10 after
implantation.
Both L-histidine and EAT growth depress the levels of blood11
glucose, liver and spleen glycogen.
The results of body weight change and organ size confirm the12
toxic character of amino acids at high concentration. (>0.25 M)
EAT growth causes size decrease in liver, spleen and kidney.13
References
Abreu, L.A., and Abreu, R.R. (1978). Changes induced by Ehrlich.
ascites carcinoma in hepatic fumarase and aconitase activities.
Experientia, 34:1536
Annau, E., Manginelli, A., and Roth, A. (1951). Increased weight and
mitotic activity in the liver of tumour-bearing rats and mice.
Cancer Res., 11:304-306
Atkinson, M.R., Morton, R.K., and Murry, A.W. (1963). Inhibition of
inosine 5'-phosphate dehydrogenase from Ehrlich ascites tumour cells
by 6-thioinosine 5'--phosphate. Biochem. J., 89:167-172
Au, K.K. (1975). The Effect of Methotrexate on the Nicotinamide
Adenine Dinucleotide Glycohydrolase Activity of Ehrlich ascites
tumour cells. M.Phil. Thesis, The Chinese University of Hong Kong
Augusti, K.T., and Mathew, P.T. (1974). Lipid lowering effect of
allicin (diallyl disulplide-oxide) on long term feeding to normal
rats. Experientia, 30:468-470
Bagshawe, K. D., and Searle, F. (1977). Tumour markers. Essays Med.
Biochem., 3:25-73
Ball, H.A., Wick, A.N. and Sanders, C. (1956). Influence of glucose
antimetabolites on the Walker tumour. Cancer Res., 16:235-239
Begg, R.W. (1958). Tumour-host relations.. Adv. Cancer Res., 5:1-54
Bekesi, J.G., Molnar, Z., and Winzier, R.J. (1969). Inhibitory effect
of D-glucosamine and other sugar analogs on the viability and
transplantibility of ascites tumour cells. Cancer Res., 29:353-359
Bergmeyer, H.U., Bernt, E., and Hess, B. (1965). Lactic dehydrogenase
In: Methods of Enzymatic Analysis (ed. by Bergmeyer, H .U.) 1st
158
English ed. pp. 736-743. Academic Press, Inc., N.Y. and London
Brenneman D.E., Mathur, S .N., and Spector, A.A. (1975). Characteri-
zation of the hyperlipidemia in mice bearing the Ehrlich ascites
tumour, Europ. J. Cancer, 11:225-230
Brin, M., and McKee, R.W. (1956). The inhibition of respiration by
glucose, fructose and mannose in the Ehrlich mouse ascites tumour.
Cancer Res., 16: 364-368
Bodansky, 0., and Schwartz, M.K. (1963). Comparative effects of L-
histidine on the activities of 5'-nucleotidase and alkaline
phosphatase. J. Biol. Chem., 238:3420-3427
Bollag, We (1971). Effect of vitamin A acid (NSC-122758) in trans-
plantable and chemically induced tumours. Cancer Chemotherapy Rept.,
55:53-58
Bounous, G., and Kongshavn, P.A.L. (1981). The effect of dietary
amino acids on the growth of tumours. Experientia, 37:271-273
Carrol, K.K. (1975). Experimental evidence of dietary factors and
hormone-dependent cancers. Cancer Res., 35:3374-3383
Carroll, K.K., and Khor, H.T. (1975). Dietary fat in relation to
tumourigenesis. Progress Biochem. Pharmacol., 10:308-353
Cavallito, C .J., and Bailey, J .H. (.1944). Allicin, the antibacterial
principle of Allium sativum. I. Isolation, physical properties and
antibacterial action. J. Am. Chem. Sci., 66:1950-1951
Cavallito, C.J., Bailey, J.H., and Buck, J.S. (1945). The anti-
bacterial principle of. Allium sativum. III. Its precursor and
essential oil of garlic. J. Am. Chem. Soc., 67:1032
Chang, M.L.W., and Johnson, M.A. (1980). Effect of garlic on
159
carbohydrate metabolism and lipid synthesis in rats. J. Nutr.,
110:931-936
Chu, E.W., and Malmgren, R.A. (1965). An inhibitory effect of vitamin
A on the induction of tumours of forestomach and cervix in the
Syrian hamster by carcinogenic polycyclic hydrocarbons. Cancer
Res., 25:884-895
Clayson, D.B. (1975). Nutrition and experimental carcinogenesis: A
review. Cancer Res., 35:3292-3300
Criss, W.E. (1971). A review of isozymes in cancer. Cancer Res.,
31:1523-1542
DeRobertis, E.D.P., Saez, F.A., and DeRobertis, E.M.F. (1975). Cell
Biology 6th ed. pp.330-331 W. B. Saunders Co., Philadephia, London,
Toronto
DeWys, W.D., and Pories, W. (1972). Inhibition of a spectrum of
animal tumours by dietary zinc deficiency. J. Natl. Cancer Inst.,
48:375-381
DiPaolo, J.A. and Carruthers, C. (1960). The effect of allicin from
garlic on tumour growth. Cancer Res., 20:431-434
DiPaolo, J.A., and Moore, G.E. (1960). The use of ascites tumours in
solid agar for screening of cancer chemotherapeutic agents. Ann.
N.Y. Acad. Sci., 76:870-881
Duncan, J.R., Dreosti, I.E., and Albrecht, C.F. (1974). Zinc intake
and growth of a transplanted hepatoma induced by 3'-methyl-4-
dimethylaminoazobenzen.e in rats. J. Natl. Cancer Inst., 53:277-278
Dunning, W.F., Curtis, M.R., and Maun, M.E. (1949). The effect of
dietary fat and carbohydrate on diethystilbestrol- induced mammary
160
cancer in rats. Cancer Res., 9:354-361
Engel, R.W., and Copeland, D.H. (19.5.1). Influence of diet on relative
incidence of eye, mammary, ear duct, and liver tumour in rats fed
2-acetylamino-fluorene. Cancer Res., 11:180-183
Engel, R.W., and Copeland, D.H. (1952). The influence of dietary
casein level on tumour induction by 2-acetylamino-fluorene. Cancer
Res., 12:905-908
Ellefson, R.S., and Caraway, W.T. (1976). Lipids and lipoproteins.
In: Fundamentals of Clinical Chemistry (ed. by Tietz. N.W.) pp .474--
541 W.B. Saunders Co.
Fountain, J.A., Parks, M.E., Dickey, A., and McKee, R.W. (1970).
Lactate dehydrogenase isozymes in tissue of normal and Ehrlich-
Lettre' ascites tumour-bearing Swiss mice. Cancer Res., 30:998-1002
Gonzalez, F.,, and Amos, H. (1977). Effect of naturally occuring
sugars in Ehrlich ascites tumour growth in mice. J. Natl. Cancer
Inst., 58:1519-1.522
Goodlad, G.A.J. (1964). Protein metabolism and tumour growth. In:
Mammalian Protein Metabolism. (ed. Monroe, H.N. and Alison, J.B.)
Vol.2, pp.415-444. Academic Press, Inc., New York
Greenstein, J.P. (1954). Nutrition. In: Biochemistry of Cancer (ed.
by Greenstein, J.P.) 2nd edition, pp. 239-260. Academic Press,
Inc., New York
Griffin, A.C., Clayton, C.C., and Baumann, C.A. (1949). Effects of
casein and methionine on retention of hepatic riboflavin and on
development of liver tumours in rats fed certain azo dyes. Cancer.
Res., 9:82-87
161
Gutmann, I., and Wahlefeld, A.W. (1974). L(+)-lactate determination
with LDH and NAD. In: Methods of Enzymatic Analysis (ed. by Bermeyer,
H.U.) Vol.3, 2nd English ed., pp1464-1468. Academic Press, Inc.,
New York and London
Harington, J. S. (1963). The sulfhydryl group and carcinogenesis.
Adv. Cancer Res., 10:247-309
Harper, A.E., Benevenga, N.J., and Wohlhneter, R.M. (1970). Effect
of ingestion of disproportionate amounts of amino acids. Physiol.
Reviews, 50:428-558
Harris, P.N.I. Krahl, M.E., and Clowes, G.H.A. (1947). Dimethyamino-
azobenzene carcinogenesis with purified diets varying in content
of cysteine, cystine, liver extract protein, riboflavin, and other
factors. Cancer Res... 7:1.62-175
Hayski, S.I., Granner, D.K., and Tomkins, G.M. (1967). Tyrosine
aminotransferase. J. Biol. Chem., 242:3998-4006
Hegyel.i,A.F., and Hegyeli, R.J. (1981). Marine antitumour agents.
In: Antitumour Compounds of Natural Origin: Chemistry and B iochemi-
stry (ed. by Aszalos, A.A.) Vol. II, ppl-25. CRC Press, Inc.
Herzfeld, A., and Greengard, 0. (1972). The dediffentiated pattern
of enzymes in livers of tumour-bearing rats. Cancer Res., 32:
1826-1832
Howell, J.S. (1958). The effect of copper acetate on p-dimethylamino-
azobenzene carcinogenesis in the rat. Brit. J. Cancer, 12:594-61.1
Jaeobi, H.P., and Baumann, CA. (1946). The effect of fat on tumour
formation. Am. J. Cancer, 39:338-342
Jamdar, S. C., and Greengard, 0. (1970). Premature formation of
162
glucokinase in developing rat liver. J. Biol. Chem., 245:2779-2783
Kamamoto, Y., Makiura, S., Sugihara, S., Hiasa, Y., Arai, M., and Ito,
K. (1973). The inhibitory effect of copper on DL-ethionine carcino-
genesis in rats. Cancer Res., 33:1129-1135
Kang-Lee, Y.A., and Harper, A.E., (1979). Effect of induction of
histidase on histidine metabolism in vivo. J. Nut!., 109:291-299
Kannan, R., and Balser, N. (1975). Tumour extracellular triglycerides
in mice during growth of Ehrlich ascites carcinoma. Lipids, 10:
770-772
Kensler, C.J., Sugiura, K., Young, N.F.,Halter, C.R., and Rhoads,,
C .P. (1941). Partial protection of rats by riboflavin with caesin
against liver cancer caused by dimethyl-aminoazobenzene. Science,
93:308-310
Klein, G. (1950). Use of the Ehrlich ascites tumour on mice for
quantitative studies on the growth and biochemistry of neoplastic
cells. Cancer, 3:1052-1061
Knox, W.E. (1967). The enzymic pattern of neoplastic tissue. Adv.
Cancer Res., 10:117-161
Kojima, Y., and Sakurada, T. (1976). Increase in alkaline phosphatase
activity in the liver of mice bearing Ehrlich ascites tumour.
Cancer Res., 36:23-27
Larsen, C.D., and Heston, W.E. (1945). Effects of cystine and carlor.ic
restriction on incidence of spontaneous pulmonary tumours in strain
A mice. J. Natl. Cancer Inst., 6:31-40
Langdon, R.G. (1966). Glucose-6-phosphate dehydrogenase from erythro-
cytes. In: Methods in Enzymology (ed. by Wood, W.A.) Vol. IX, pp126-
163
131. Academic Press, Inc., N.Y. and London
Lavik, P.S., and Baumann,C.A. (1943). Further studies on the tumour-
promoting action of fat. Cancer Res., 3:749--756
Lea, A.J. (1966). Dietary factors associated with death-rats from
certain neoplasms in man. Lancet, 1:332-333
Lehninger, A.L. (1975). Biochemistry 2nd ed. pp.828-852 Worth
Publishers, Inc., New York
Linhardt, K., and Walter, K. (1965). Phosphatase (Phosphomonoester-
ase). In: Methods of Enzymic Analysis (ed. by Bergmeyer, H.U.) lst
English ed. pp.779-787. Academic Press, Inc., N.Y. London
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951).
Protein measurement with the Folin-phenol reagent. J. Biol. Chem.,
193:265-275
Lundholm, K., Edstrom, S., Ekman, L., Karlbeig, I., Bylund, A-C., and
Scherste.n, T. (1978). A comparative study of the influence of
malignant tumour on host metabolism in mice and man. Evaluation of
an experimental model. Cancer, 42:453-461
Lundholm, K... Ekman, L., Edstrom, S., Karlberg, I., Jagenburg, R.,
and Schersten, T. (1979). Protein synthesis in liver tissue under
the influence of a methylcholanthrene-induced Sarcoma in mice.
Cancer Res., 39:4657-4661
Madhaven, T.V., Goplan, C., and Hyderabad, T. (1965). Effect of
dietary protein on aflatoxin liver injury in weanling rats, Arch.
Pathol., 80:123-126
Mahin, D .T., and Lofberg, R.T. (1966). A simplified method of sample
preparation for determination of tritium, carbon -14, or sulfur -35
164
in blood or tissue by liquid scintillation counting. Analytical
Biochem., 16 :500-509
Mandelstam, J., and Yudkin, J. (1952). Studies in biochemical
adaptation. The effect of variation in dietary protein upon the
hepatic arginase of the rat. Biochem. J., 51:681-686
Marshall, M.J., Neal, F.E., and Goldberg, D.M. (1979). Isoenzyines of
hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase
and lactate dehydrogenase in uterine cancer. Brit. J. Cancer, 40:
380-390
McGlashan, N.D. (1972). Zinc and oesophageal cancer. Lancet, 1:578
McLean, A. E .M., and Magee, P.W. (1970). Increased renal carcinogenesis
by dimethyl nitrosamine in protein deficient rats. Brit. J. Exp.
Pathol., 51:587-590
Meister, A. (1965). The role of amino acids in nutrition In: Biochemi-
stry of the Amino Acids (ed. by Meister, A.) 2nd ed. Vol. 1, pp.201-
268. Academic Press, Inc., New York and London
Mellanby, J., and Williamson, D.H. (1965). Acetoacetate. In: Methods
of Enzymatic Analysis (ed. by Bergmeyer, H.U.) 1st English ed.
pp.454-458. Academic Press, Inc., New York and London
Mermier, P., and Baker, N. (1974). Flux of free fatty acids among
host tissues, ascites fluid, and Ehrlich ascites carcinoma cells.
J. Lipid Res., 15:339-351
Milner, J.A. and Stepanovich, L.V. (1979). Inhibitory effect of
dietary arginine on growth of Ehrlich ascites tumour cells in mice.
J. Nutr., 109 :489-494
Minkel, D.T., Dolhun, P.J., Calhoun, B.L., Saryan, L.A., and Petering,
165
D.H., (1979). Zinc deficiency and growth Ehrlich ascites tumour.
Cancer Res., 39:2451-2456
Moore, C., and Tittle, P.W. (1973). Muscle activity, body fat, and
induced rat mammary tumours. Surgery, 73:329--332
Nakamura, W., and Hosoda, S. (1968). The absence of glucose in
Ehrlich ascites tumour cells and fluid. Biochem. Biophys. Acta,
158:21.2-218
Norberg, E., and Greenberg, D.M. (1951). Incorporation of labeled
glycine in the proteins of tissues of non,tal and tumour-bearing
mice. Cancer, 4:383-386
Patt, H.M. (1960). Parameters of ascites tumour growth. Ann. N.Y.
Acad. Sci. 76:572-574
Pine, M.J. (1978). Effect of low phenylalanine diet on Murine
leukemia L1210. J. Natl. Cancer Inst., 60:633-641
Poirier, L.A., and Boutwell, R.K. (1975). Symposium: Current problems
in nutrition and cancer. Fed. Proc., 35:1307-1332
Pories, W.J., DeWys, W.D., Flynn, A., Mansour, E.G., and Strain, W.H.
(1978). Implications of the inhibition of animal tumours by
dietary zinc deficiency. Adv. Experimental Med. Biol., 91:243-257
Pryme, I.F. (1.976). The failure of growth of a mouse myeloma tumour
during the course of oral administration of L-arginine hydrochloride.
Cancer Letters, 1:177-182
Pryme, I.F. (1978). The effects of orally administrated L-arginine
HC1 on the development of myeloma tumours in Ba.lb /C following the
injection of single cell suspensions, cell aggregates or tumour
fragment; and on the growth of two ascites tumour cell lines.
166
Cancer Letters, 5 :19-23
Ookhtens, M., and Baker, N. (1979). Evaluation of impaired trig.lyce-
ride fatty acid transport and oxidation for the detection of cancer
in mice. Cancer Res., 39:5118-5123
Reddy, B.S., Cohen, L.A., McCoy, G.D., Hill, P., Weisburger, J.H.,
and Wynder, E.L. (1980). Nutrition and its relationship to cancer.
Adv. Cancer Res., 32:237-345
Rhodin, J.A.G. (1974). Histology: A Text and Atlas. pp.553-577. New
York Oxford University Press- London and Toronto
Riley, V., Lilly, F., Huerto, E., and Bardell, D. (1960). Transmis-
sible agent associated with 26 types of experimental mouse neo-
plasms. Science, 132:545-547
Riley, V., and. Wroblewski, F. (1960). Serial lactic dehydrogenase
activity in plasma of mice with growing or regressing tumours.
Science, 132:151-152
Roehrig, K.L. and Allred, J.B. (1974). Direct enzymatic procedure for
the determination of liver glycogen. Analytical Biochem., 58:414-
421
Ross, M.H., Bras, G., and Ragbeer, M.S. (1970). Influence of protein
and caloric intake upon spontaneous tumour incidence of i.he anterior
pituitary gland of the rat. J. Nutr., 100:1.77-189
Rous, P. (1914). The influence of diet on transplanted and spontaneous
mouse tumours. J. Expt. Med., 30:433-449
Sahib, M.K., and Murti, C.R.K. (1969). Induction of histidine-
degrating enzymes in protein-starved rats and regulation of
histidine metabolism. J. Biol. Chem., 244:4730-4734
167
Saxton, J.A., Boon, M.C., and Furth, J. (1944). Observations on
inhibition of development of spontaneous leukemia in mice by under-
feeding. Cancer Res., 4:401-409
Schapira, F. (1973). Isozymes and cancer. Adv. Cancer Res., 18:77-
153
Schimke, R.T. (1962). Adaptive characteristics of urea cycle enzymes
in the rat. J. Biol. Chem., 237:459-468
Schrauzer, G.N. (1978). Trace elements, nurtition and cancer: Per-
spectives of prevention. Adv. Experimental Med. Biol. 91:323-344
Schrauzer, G.N., White, D.A., and Schneider, C.J. (1977). Cancer
mortality correlation studies- III: Statistical associations with
dietary selenium intakes. Bioinorganic Chem., 7:23-34
Shamberger, R.J. (1970). Inhibitory effect of vitamin A on carcino-
genesis. J. Natl. Cancer Inst., 47:667-673
Shamberger, R.J., Tytko, S.A., and Wills, C.E. (1976). Antioxidants
and cancer- Part VI: Selenium and aged- adjusted human cancer
mortality. Arch. Environmental Health, 31:231-235
Shapot, V. S. (1968). Some biochemical aspects of the relationship
between the tumour and the host. Adv. Cancer Res., 15:253--286
Silverstone, H., and Tannenbaum, A. (1950). The effect of proportion
of dietary fat on the rate of formation of mammary carcinoma in
mice. Cancer Res., 10:448-453
Silverstone, H., and Tannenbaum, A. (1951a). The influence of dietary
fat and riboflavin on the formation of spontaneous hepatomas in the
mouse. Cancer Res., 11:442-446
Silverstone, H., and Tannenbaum, A. (1951b). Proportion of dietary
168
protein and formation of spontaneous hepatomas in mice. Cancer Res.,
11:200-203
Silverstone, H., and Tannenbaum, A. (1953). Dietary protein and
sulfur-containing amino acids in relation to the genesis of spontane-
ous hepatomas. Proc. Am. Assoc. Cancer Res., 1:51-55
Slaughter, D.P. (1959). An introduction to cancer and cancer diagnosis.
In': Cancer: Diagnosis and Treatment (ed. by Field, J .B.) pp. 1-27.
Little, Brown Co.
Soloman, J.K., and Geison, R.L. (1978). Effect of excess dietary L-
histidine on plasma cholesterol levels in weanling rats. J. Nutr.,
108:936-943
Sporn, M.B., Dunlop, N.M., Newton, D.L., and Smith, J.M. (1976).
Prevention of Chemical carcinogenesis by vitamin A and its synthetic
analogs (retinoids). Fed. Proc., 35:1332-1338
Stocks, P., and Davis, R.I. (1964). Zinc an6 copper content of soils
associated with the incidence of cancer of stomach and other organs.
Brit. J. Cancer., 18:14-24
Stoll, A., and Seeback, E. (1951). Chemical investigations on alliin,
the specific principle of garlic. Adv. Enzymology, 11:377-400
Tannenbaum, A.0940). Initiation and growth of tumours: Effects of
underfeeding. Am. J. Cancer, 38:335-350
Tannenbaum, A.(1942). The genesis and growth of tumours. III. Effects
of a high-fat diet. Cancer Res., 2 :468-474
Tannenbaum, A. and Silverstone, H. (1949). The influence of the
degree of carloric restriction on the formation of skin tumours and
hepatomas in mice. Cancer Res., 9:724-727
169
Tannenbaum, A.5 and Silverstone, H. (1953). Nutrition in relation
to cancer. Advan. Cancer Res., 1:451-501
Tannenbaum, A.5 and Silverstone, H. (1957). Nutrition and the genesis
of tumours. In: Cancer (ed. by Raven, R.W.) Val. 1, pp .306-334.
Butterworth & Co., Ltd., London
Wadkins, C.L., and Lehninger, A.L. (1963). Preparation and assay of
phosphorylating submitochondrial particles. In: Methods in Enzyrno-
logy.. (ed. by Colowick., S. P., and Kaplan, N. 0) Vol. VI. pp. 265-
272. Acad. Press. N.Y. and London
Walters, M.A., and Roe, F.J.C. (1964). The effect of dietary casein
on the induction of lung tumours by the injection of 9 ,10-dimethyl-
1 ,2-benzanthracene (DMBA) into newborn mice. Brit. J. Cancer, 18:
312-316
Waxler, S .H., Tabar, P., and Melcher, L. R., (1953). Obesity and time
of appearance of spontaneous mammary carcinoma in C3H mice. Cancer
Res., 13:276-278
Weber, G. (1976). Enzymic strategy of. 1--he cancer cell. In: Cancer
Enzymology (ed. by Schultz, J. and Ahmad, F.) pp.63-117. Academic
Press, Inc., New York, San Franciso, London
Weinhouse, S. (1971). Isozymes in cancer. Cancer Res., 31:1166-1.167
Weisberger, A. S., and Pensky, J. (1957). Tumour-inhibiting effects
derived from an active principle of garlic (Allium sativum). Sci.,
126:1112-1114
Weisberger, A.S., and Pensky, J. (1958). Tumour inhibition by a
sulfhydryl-blocking agent related to an active principle of garlic
(Allium sativum). Cancer Res., 18:1301-1308
170
Wells, P.,, Aftergood, L., and Alfin-Slater, R.B. (1976). The effect
of varying levels of dietary protein on tumours development and
lipid metabolism in rats exposed to aflatoxin. J. Aare. Oil. Chem.
Soc., 53:559
Wells, P., and Alf-in-Slater, R.B. (1979). The relationship of diet
and nutritional status to cancer, In: Nutrition, Metabolic and
Clinical Apeic .t ions. (ed. by Hoges, R. B.). pp .183---217. Plen. ~n
Press, New York and London
Wheatley, D.N., Ambrose, E.J., and Easty, G.C. (1963). Infiltration
of intra-abdominal organs by asci:tes tumours. Nature, 199:1.88-1.89
White, F.R. (1960). The relationship hetwen underfeeding and tumour
formation, transplantation, and growth in rats and mice. Cancer
Res., 21:281-290
and Mider, G.B. (1947). Effect of dietsWhite, J.,, White, F.R. .
deficient in certain amino acids on induction of leukemia in. DBA
Mice. J. Natl. Cancer Inst.,, 7:199-202
Williamson, D.H., and yMellanby, J.(1965). D(-)-p-hydroxybutyrate.
In: Methods of Enzymatic Analysis. (ed. by Ser Meyer. 1st English
ed. pp.459-461. Academic Press, Inc., New York and London
Yamada, N.' (1977). Effect of dietary DL--ethionine ar,.d,/or DL-methio-
nine on egg laying and activities of some cytoplasmic NAD linked--
dehydrogenases and NADPIi producing enzymes in liver of Japanese
quail, Coturnix coturnix japonica. J. Nutr., 107:716-7123
Yamada, Y., and Azuma, K. (1977). Evaluation of the M.c2 vi tJO anti-
fungal activity of allic3n.. Antimicrobial Agents and Chemotherapy,
11:743-749
Yeakel, E.H. (1948). Increased weight of the liver in Wistar albino
rats with induced and transplanted tumours. Cancer Res., 8:392-396
TJlm, E.H., Pogell, B.M., DeMaine, M.M., Libby, C.B., and Benkovic,
S.J. (1975). Fru.ctose-1 ,6-diphosphatase from rabbit liver. In:
Methods in Enzymology (ed. by Wood, W.A.) Vol. XLII, pp.369-374.
Academic Press, Inc., N.Y. and London
Zlatkis, A., Zak, B., and Boyle, A.J. (1953). A new method for the
direct determination of serum cholesterol. J. Lab. Clin. Med.,
41 :486-492
1,‘.I4


